| 4.6 |
4.6 |
GO:0072048 |
pattern specification involved in kidney development(GO:0061004) renal system pattern specification(GO:0072048) |
| 4.4 |
13.2 |
GO:0014028 |
notochord formation(GO:0014028) |
| 4.3 |
12.8 |
GO:0006546 |
glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
| 4.2 |
20.8 |
GO:0021905 |
pancreatic A cell development(GO:0003322) forebrain-midbrain boundary formation(GO:0021905) somatic motor neuron fate commitment(GO:0021917) regulation of transcription from RNA polymerase II promoter involved in somatic motor neuron fate commitment(GO:0021918) |
| 4.1 |
16.4 |
GO:0003199 |
endocardial cushion to mesenchymal transition involved in heart valve formation(GO:0003199) |
| 4.0 |
12.1 |
GO:0060853 |
arterial endothelial cell fate commitment(GO:0060844) blood vessel endothelial cell fate commitment(GO:0060846) endothelial cell fate specification(GO:0060847) Notch signaling pathway involved in arterial endothelial cell fate commitment(GO:0060853) blood vessel endothelial cell fate specification(GO:0097101) |
| 4.0 |
12.1 |
GO:0060364 |
frontal suture morphogenesis(GO:0060364) |
| 3.7 |
11.2 |
GO:0060598 |
dichotomous subdivision of terminal units involved in mammary gland duct morphogenesis(GO:0060598) |
| 3.7 |
11.0 |
GO:0030421 |
defecation(GO:0030421) |
| 3.5 |
7.1 |
GO:0072180 |
mesonephric duct development(GO:0072177) mesonephric duct morphogenesis(GO:0072180) |
| 3.5 |
13.8 |
GO:0007228 |
positive regulation of hh target transcription factor activity(GO:0007228) |
| 3.4 |
10.2 |
GO:0048352 |
neural plate mediolateral regionalization(GO:0021998) mesoderm structural organization(GO:0048338) paraxial mesoderm structural organization(GO:0048352) |
| 3.2 |
15.9 |
GO:0070345 |
negative regulation of fat cell proliferation(GO:0070345) |
| 3.0 |
12.2 |
GO:0018242 |
protein O-linked glycosylation via serine(GO:0018242) |
| 3.0 |
15.2 |
GO:0006447 |
regulation of translational initiation by iron(GO:0006447) positive regulation of translational initiation by iron(GO:0045994) |
| 2.9 |
2.9 |
GO:0042660 |
positive regulation of cell fate specification(GO:0042660) |
| 2.9 |
2.9 |
GO:0072076 |
nephrogenic mesenchyme development(GO:0072076) |
| 2.7 |
8.1 |
GO:0060994 |
regulation of transcription from RNA polymerase II promoter involved in kidney development(GO:0060994) |
| 2.6 |
10.5 |
GO:0070858 |
negative regulation of bile acid biosynthetic process(GO:0070858) negative regulation of bile acid metabolic process(GO:1904252) |
| 2.6 |
25.8 |
GO:0060272 |
embryonic skeletal joint morphogenesis(GO:0060272) |
| 2.5 |
7.6 |
GO:0003162 |
atrioventricular node development(GO:0003162) |
| 2.5 |
7.5 |
GO:0035878 |
nail development(GO:0035878) |
| 2.5 |
14.8 |
GO:0003383 |
apical constriction(GO:0003383) |
| 2.5 |
7.4 |
GO:0070844 |
misfolded protein transport(GO:0070843) polyubiquitinated protein transport(GO:0070844) polyubiquitinated misfolded protein transport(GO:0070845) Hsp90 deacetylation(GO:0070846) |
| 2.4 |
7.1 |
GO:0046370 |
fructose biosynthetic process(GO:0046370) |
| 2.4 |
7.1 |
GO:0007223 |
Wnt signaling pathway, calcium modulating pathway(GO:0007223) |
| 2.3 |
9.4 |
GO:0000255 |
allantoin metabolic process(GO:0000255) |
| 2.3 |
7.0 |
GO:1900275 |
negative regulation of phospholipase C activity(GO:1900275) |
| 2.3 |
2.3 |
GO:0061484 |
hematopoietic stem cell homeostasis(GO:0061484) |
| 2.3 |
2.3 |
GO:0045976 |
negative regulation of mitotic cell cycle, embryonic(GO:0045976) |
| 2.3 |
2.3 |
GO:0045909 |
positive regulation of vasodilation(GO:0045909) |
| 2.2 |
6.7 |
GO:1904395 |
regulation of skeletal muscle acetylcholine-gated channel clustering(GO:1904393) positive regulation of skeletal muscle acetylcholine-gated channel clustering(GO:1904395) |
| 2.2 |
4.4 |
GO:2000977 |
negative regulation of mechanoreceptor differentiation(GO:0045632) negative regulation of pro-B cell differentiation(GO:2000974) regulation of forebrain neuron differentiation(GO:2000977) negative regulation of inner ear receptor cell differentiation(GO:2000981) |
| 2.2 |
10.9 |
GO:0007089 |
traversing start control point of mitotic cell cycle(GO:0007089) |
| 2.1 |
10.4 |
GO:0036302 |
atrioventricular canal development(GO:0036302) |
| 2.0 |
6.1 |
GO:0016332 |
establishment or maintenance of polarity of embryonic epithelium(GO:0016332) |
| 2.0 |
6.0 |
GO:0086017 |
Purkinje myocyte action potential(GO:0086017) |
| 2.0 |
5.9 |
GO:0003360 |
brainstem development(GO:0003360) |
| 1.9 |
15.4 |
GO:0048852 |
diencephalon morphogenesis(GO:0048852) |
| 1.9 |
7.7 |
GO:0072137 |
condensed mesenchymal cell proliferation(GO:0072137) |
| 1.9 |
5.8 |
GO:0021759 |
globus pallidus development(GO:0021759) |
| 1.9 |
7.6 |
GO:0071680 |
response to indole-3-methanol(GO:0071680) cellular response to indole-3-methanol(GO:0071681) |
| 1.9 |
9.4 |
GO:0046654 |
tetrahydrofolate biosynthetic process(GO:0046654) |
| 1.9 |
3.7 |
GO:1904059 |
regulation of locomotor rhythm(GO:1904059) |
| 1.9 |
18.6 |
GO:0021521 |
ventral spinal cord interneuron specification(GO:0021521) cell fate specification involved in pattern specification(GO:0060573) |
| 1.8 |
3.7 |
GO:0060838 |
lymphatic endothelial cell fate commitment(GO:0060838) regulation of transcription involved in lymphatic endothelial cell fate commitment(GO:0060849) |
| 1.8 |
3.7 |
GO:0036518 |
chemorepulsion of dopaminergic neuron axon(GO:0036518) |
| 1.8 |
1.8 |
GO:0001885 |
endothelial cell development(GO:0001885) |
| 1.8 |
10.8 |
GO:1903755 |
regulation of SUMO transferase activity(GO:1903182) positive regulation of SUMO transferase activity(GO:1903755) |
| 1.8 |
7.2 |
GO:2001032 |
regulation of double-strand break repair via nonhomologous end joining(GO:2001032) |
| 1.8 |
14.2 |
GO:0050882 |
voluntary musculoskeletal movement(GO:0050882) |
| 1.8 |
5.3 |
GO:0071649 |
regulation of chemokine (C-C motif) ligand 5 production(GO:0071649) |
| 1.8 |
15.8 |
GO:0046499 |
S-adenosylmethioninamine metabolic process(GO:0046499) |
| 1.8 |
14.1 |
GO:0030174 |
regulation of DNA-dependent DNA replication initiation(GO:0030174) |
| 1.7 |
5.2 |
GO:0032474 |
otolith morphogenesis(GO:0032474) |
| 1.7 |
6.8 |
GO:0035606 |
peptidyl-cysteine S-trans-nitrosylation(GO:0035606) |
| 1.7 |
15.3 |
GO:0045719 |
negative regulation of glycogen biosynthetic process(GO:0045719) negative regulation of glycogen metabolic process(GO:0070874) |
| 1.7 |
8.4 |
GO:0003420 |
regulation of growth plate cartilage chondrocyte proliferation(GO:0003420) |
| 1.7 |
6.7 |
GO:0070829 |
heterochromatin maintenance(GO:0070829) |
| 1.7 |
3.4 |
GO:0021797 |
forebrain anterior/posterior pattern specification(GO:0021797) |
| 1.7 |
5.0 |
GO:1903225 |
negative regulation of endodermal cell differentiation(GO:1903225) |
| 1.6 |
4.9 |
GO:1903998 |
regulation of eating behavior(GO:1903998) |
| 1.6 |
18.1 |
GO:1902459 |
positive regulation of stem cell population maintenance(GO:1902459) |
| 1.6 |
1.6 |
GO:0009786 |
regulation of asymmetric cell division(GO:0009786) |
| 1.6 |
4.9 |
GO:1902498 |
regulation of protein autoubiquitination(GO:1902498) |
| 1.6 |
4.9 |
GO:0060217 |
hemangioblast cell differentiation(GO:0060217) |
| 1.6 |
3.2 |
GO:2000048 |
negative regulation of cell-cell adhesion mediated by cadherin(GO:2000048) |
| 1.6 |
1.6 |
GO:2000177 |
regulation of neural precursor cell proliferation(GO:2000177) |
| 1.6 |
11.1 |
GO:1904667 |
negative regulation of ubiquitin protein ligase activity(GO:1904667) |
| 1.6 |
1.6 |
GO:0061642 |
chemoattraction of axon(GO:0061642) |
| 1.6 |
1.6 |
GO:0072070 |
loop of Henle development(GO:0072070) metanephric loop of Henle development(GO:0072236) |
| 1.5 |
13.9 |
GO:0051574 |
positive regulation of histone H3-K9 methylation(GO:0051574) |
| 1.5 |
4.6 |
GO:0021849 |
neuroblast division in subventricular zone(GO:0021849) |
| 1.5 |
4.6 |
GO:1900041 |
negative regulation of interleukin-2 secretion(GO:1900041) |
| 1.5 |
6.1 |
GO:0033326 |
cerebrospinal fluid secretion(GO:0033326) |
| 1.5 |
10.5 |
GO:0030903 |
notochord development(GO:0030903) |
| 1.5 |
1.5 |
GO:0033122 |
regulation of purine nucleotide catabolic process(GO:0033121) negative regulation of purine nucleotide catabolic process(GO:0033122) |
| 1.5 |
2.9 |
GO:0051295 |
establishment of meiotic spindle localization(GO:0051295) |
| 1.5 |
5.9 |
GO:1900145 |
regulation of nodal signaling pathway involved in determination of left/right asymmetry(GO:1900145) regulation of nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry(GO:1900175) positive regulation of nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry(GO:1900224) positive regulation of mesoderm development(GO:2000382) |
| 1.5 |
4.4 |
GO:0009177 |
deoxyribonucleoside monophosphate biosynthetic process(GO:0009157) pyrimidine deoxyribonucleoside monophosphate biosynthetic process(GO:0009177) |
| 1.4 |
4.3 |
GO:1901675 |
negative regulation of histone H3-K27 acetylation(GO:1901675) |
| 1.4 |
4.3 |
GO:0048496 |
maintenance of organ identity(GO:0048496) |
| 1.4 |
2.9 |
GO:0046122 |
purine deoxyribonucleoside metabolic process(GO:0046122) |
| 1.4 |
8.6 |
GO:0038031 |
non-canonical Wnt signaling pathway via JNK cascade(GO:0038031) |
| 1.4 |
1.4 |
GO:0007354 |
zygotic determination of anterior/posterior axis, embryo(GO:0007354) |
| 1.4 |
24.0 |
GO:0021516 |
dorsal spinal cord development(GO:0021516) |
| 1.4 |
2.8 |
GO:2000744 |
anterior head development(GO:0097065) regulation of anterior head development(GO:2000742) positive regulation of anterior head development(GO:2000744) |
| 1.4 |
4.1 |
GO:0040009 |
regulation of growth rate(GO:0040009) |
| 1.4 |
15.1 |
GO:0007440 |
foregut morphogenesis(GO:0007440) embryonic foregut morphogenesis(GO:0048617) |
| 1.4 |
1.4 |
GO:0051595 |
response to methylglyoxal(GO:0051595) |
| 1.4 |
4.1 |
GO:0006106 |
fumarate metabolic process(GO:0006106) |
| 1.3 |
8.1 |
GO:0036089 |
cleavage furrow formation(GO:0036089) |
| 1.3 |
2.7 |
GO:0031052 |
programmed DNA elimination(GO:0031049) chromosome breakage(GO:0031052) |
| 1.3 |
6.6 |
GO:1902570 |
protein localization to nucleolus(GO:1902570) |
| 1.3 |
5.3 |
GO:0061188 |
regulation of chromatin silencing at rDNA(GO:0061187) negative regulation of chromatin silencing at rDNA(GO:0061188) |
| 1.3 |
9.2 |
GO:0033567 |
DNA replication, Okazaki fragment processing(GO:0033567) |
| 1.3 |
5.2 |
GO:0046836 |
glycolipid transport(GO:0046836) |
| 1.3 |
3.9 |
GO:0045819 |
positive regulation of glycogen catabolic process(GO:0045819) |
| 1.3 |
5.2 |
GO:1901165 |
positive regulation of trophoblast cell migration(GO:1901165) |
| 1.3 |
3.9 |
GO:0060489 |
establishment of body hair or bristle planar orientation(GO:0048104) establishment of body hair planar orientation(GO:0048105) orthogonal dichotomous subdivision of terminal units involved in lung branching morphogenesis(GO:0060488) planar dichotomous subdivision of terminal units involved in lung branching morphogenesis(GO:0060489) lateral sprouting involved in lung morphogenesis(GO:0060490) |
| 1.3 |
5.1 |
GO:0071394 |
cellular response to testosterone stimulus(GO:0071394) |
| 1.3 |
18.8 |
GO:0071459 |
protein localization to chromosome, centromeric region(GO:0071459) |
| 1.2 |
7.5 |
GO:0000022 |
mitotic spindle elongation(GO:0000022) mitotic spindle midzone assembly(GO:0051256) |
| 1.2 |
2.5 |
GO:0021557 |
oculomotor nerve development(GO:0021557) |
| 1.2 |
3.7 |
GO:1903334 |
positive regulation of protein folding(GO:1903334) |
| 1.2 |
3.7 |
GO:0050929 |
corticospinal neuron axon guidance(GO:0021966) corticospinal neuron axon guidance through spinal cord(GO:0021972) positive regulation of negative chemotaxis(GO:0050924) induction of negative chemotaxis(GO:0050929) negative regulation of mononuclear cell migration(GO:0071676) negative regulation of retinal ganglion cell axon guidance(GO:0090260) |
| 1.2 |
2.5 |
GO:0010725 |
regulation of primitive erythrocyte differentiation(GO:0010725) |
| 1.2 |
4.9 |
GO:1903011 |
negative regulation of bone development(GO:1903011) |
| 1.2 |
4.9 |
GO:0046061 |
dATP catabolic process(GO:0046061) |
| 1.2 |
4.9 |
GO:0038027 |
apolipoprotein A-I-mediated signaling pathway(GO:0038027) |
| 1.2 |
6.1 |
GO:1903715 |
regulation of aerobic respiration(GO:1903715) |
| 1.2 |
1.2 |
GO:0030656 |
regulation of vitamin metabolic process(GO:0030656) |
| 1.2 |
6.0 |
GO:0072257 |
metanephric nephron tubule epithelial cell differentiation(GO:0072257) regulation of metanephric nephron tubule epithelial cell differentiation(GO:0072307) |
| 1.2 |
10.7 |
GO:0002536 |
respiratory burst involved in inflammatory response(GO:0002536) |
| 1.2 |
7.1 |
GO:0085020 |
protein K6-linked ubiquitination(GO:0085020) |
| 1.2 |
1.2 |
GO:0014823 |
response to activity(GO:0014823) |
| 1.2 |
12.9 |
GO:0021796 |
cerebral cortex regionalization(GO:0021796) |
| 1.1 |
1.1 |
GO:0033182 |
regulation of histone ubiquitination(GO:0033182) |
| 1.1 |
1.1 |
GO:0042359 |
vitamin D metabolic process(GO:0042359) |
| 1.1 |
4.5 |
GO:0043973 |
histone H3-K4 acetylation(GO:0043973) |
| 1.1 |
2.3 |
GO:1905206 |
positive regulation of hydrogen peroxide-mediated programmed cell death(GO:1901300) positive regulation of hydrogen peroxide-induced cell death(GO:1905206) |
| 1.1 |
16.9 |
GO:0006337 |
nucleosome disassembly(GO:0006337) protein-DNA complex disassembly(GO:0032986) |
| 1.1 |
1.1 |
GO:0000320 |
re-entry into mitotic cell cycle(GO:0000320) |
| 1.1 |
3.3 |
GO:0007161 |
calcium-independent cell-matrix adhesion(GO:0007161) |
| 1.1 |
6.6 |
GO:0035087 |
siRNA loading onto RISC involved in RNA interference(GO:0035087) |
| 1.1 |
2.2 |
GO:2000191 |
regulation of fatty acid transport(GO:2000191) |
| 1.1 |
2.2 |
GO:0000715 |
nucleotide-excision repair, DNA damage recognition(GO:0000715) |
| 1.1 |
4.4 |
GO:0097527 |
necroptotic signaling pathway(GO:0097527) |
| 1.1 |
2.2 |
GO:0070425 |
negative regulation of nucleotide-binding oligomerization domain containing signaling pathway(GO:0070425) negative regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway(GO:0070433) |
| 1.1 |
9.8 |
GO:0046459 |
short-chain fatty acid metabolic process(GO:0046459) |
| 1.1 |
4.3 |
GO:0010387 |
COP9 signalosome assembly(GO:0010387) |
| 1.1 |
6.5 |
GO:0000733 |
DNA strand renaturation(GO:0000733) |
| 1.1 |
5.3 |
GO:1904690 |
regulation of cap-independent translational initiation(GO:1903677) positive regulation of cap-independent translational initiation(GO:1903679) regulation of cytoplasmic translational initiation(GO:1904688) positive regulation of cytoplasmic translational initiation(GO:1904690) |
| 1.1 |
1.1 |
GO:1901536 |
regulation of DNA demethylation(GO:1901535) negative regulation of DNA demethylation(GO:1901536) |
| 1.1 |
2.1 |
GO:0090526 |
regulation of gluconeogenesis involved in cellular glucose homeostasis(GO:0090526) |
| 1.0 |
8.4 |
GO:0032525 |
somite rostral/caudal axis specification(GO:0032525) |
| 1.0 |
6.3 |
GO:0031536 |
positive regulation of exit from mitosis(GO:0031536) |
| 1.0 |
2.1 |
GO:0031936 |
negative regulation of chromatin silencing(GO:0031936) |
| 1.0 |
4.1 |
GO:2000271 |
positive regulation of fibroblast apoptotic process(GO:2000271) |
| 1.0 |
2.1 |
GO:0044340 |
canonical Wnt signaling pathway involved in regulation of cell proliferation(GO:0044340) |
| 1.0 |
24.7 |
GO:0045880 |
positive regulation of smoothened signaling pathway(GO:0045880) |
| 1.0 |
3.1 |
GO:0044778 |
meiotic DNA integrity checkpoint(GO:0044778) |
| 1.0 |
3.1 |
GO:0007084 |
mitotic nuclear envelope reassembly(GO:0007084) |
| 1.0 |
5.1 |
GO:0071896 |
protein localization to adherens junction(GO:0071896) |
| 1.0 |
6.1 |
GO:0016078 |
tRNA catabolic process(GO:0016078) |
| 1.0 |
6.1 |
GO:0021978 |
telencephalon regionalization(GO:0021978) |
| 1.0 |
3.0 |
GO:0060558 |
regulation of calcidiol 1-monooxygenase activity(GO:0060558) |
| 1.0 |
5.0 |
GO:0030091 |
protein repair(GO:0030091) |
| 1.0 |
3.0 |
GO:0019659 |
glucose catabolic process to lactate(GO:0019659) glycolytic fermentation(GO:0019660) glucose catabolic process to lactate via pyruvate(GO:0019661) |
| 1.0 |
1.0 |
GO:0019249 |
lactate biosynthetic process from pyruvate(GO:0019244) lactate biosynthetic process(GO:0019249) |
| 1.0 |
5.0 |
GO:0006987 |
activation of signaling protein activity involved in unfolded protein response(GO:0006987) |
| 1.0 |
13.0 |
GO:0030948 |
negative regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030948) |
| 1.0 |
2.0 |
GO:0043696 |
dedifferentiation(GO:0043696) cell dedifferentiation(GO:0043697) |
| 1.0 |
1.0 |
GO:0031570 |
DNA integrity checkpoint(GO:0031570) |
| 1.0 |
4.0 |
GO:0072365 |
regulation of cellular ketone metabolic process by negative regulation of transcription from RNA polymerase II promoter(GO:0072365) |
| 1.0 |
5.0 |
GO:0014719 |
skeletal muscle satellite cell activation(GO:0014719) |
| 1.0 |
5.0 |
GO:0040032 |
post-embryonic body morphogenesis(GO:0040032) |
| 1.0 |
4.9 |
GO:0070934 |
CRD-mediated mRNA stabilization(GO:0070934) |
| 1.0 |
8.9 |
GO:0048386 |
positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
| 1.0 |
5.9 |
GO:0006177 |
GMP biosynthetic process(GO:0006177) |
| 1.0 |
4.9 |
GO:0042997 |
negative regulation of Golgi to plasma membrane protein transport(GO:0042997) |
| 1.0 |
2.9 |
GO:0002184 |
cytoplasmic translational termination(GO:0002184) |
| 1.0 |
10.7 |
GO:0033234 |
negative regulation of protein sumoylation(GO:0033234) |
| 1.0 |
2.9 |
GO:0045578 |
negative regulation of B cell differentiation(GO:0045578) |
| 1.0 |
3.9 |
GO:0072202 |
cell differentiation involved in metanephros development(GO:0072202) |
| 1.0 |
3.9 |
GO:0010510 |
regulation of acetyl-CoA biosynthetic process from pyruvate(GO:0010510) |
| 1.0 |
2.9 |
GO:2000686 |
regulation of rubidium ion transmembrane transporter activity(GO:2000686) |
| 1.0 |
2.9 |
GO:0043267 |
negative regulation of potassium ion transport(GO:0043267) |
| 1.0 |
3.8 |
GO:0031581 |
hemidesmosome assembly(GO:0031581) |
| 1.0 |
3.8 |
GO:0046726 |
positive regulation by virus of viral protein levels in host cell(GO:0046726) |
| 1.0 |
15.3 |
GO:0048387 |
negative regulation of retinoic acid receptor signaling pathway(GO:0048387) |
| 1.0 |
1.9 |
GO:0035743 |
T cell cytokine production(GO:0002369) CD4-positive, alpha-beta T cell cytokine production(GO:0035743) T-helper 2 cell cytokine production(GO:0035745) |
| 1.0 |
2.9 |
GO:0002842 |
T cell mediated immune response to tumor cell(GO:0002424) regulation of T cell mediated immune response to tumor cell(GO:0002840) positive regulation of T cell mediated immune response to tumor cell(GO:0002842) |
| 1.0 |
1.9 |
GO:2001027 |
negative regulation of endothelial cell chemotaxis(GO:2001027) |
| 0.9 |
18.9 |
GO:0006999 |
nuclear pore organization(GO:0006999) |
| 0.9 |
2.8 |
GO:0033860 |
regulation of NAD(P)H oxidase activity(GO:0033860) |
| 0.9 |
10.4 |
GO:0046643 |
regulation of gamma-delta T cell differentiation(GO:0045586) regulation of gamma-delta T cell activation(GO:0046643) |
| 0.9 |
1.9 |
GO:0032493 |
response to bacterial lipoprotein(GO:0032493) |
| 0.9 |
2.8 |
GO:0032053 |
ciliary basal body organization(GO:0032053) |
| 0.9 |
23.6 |
GO:0006270 |
DNA replication initiation(GO:0006270) |
| 0.9 |
7.5 |
GO:0045830 |
positive regulation of isotype switching(GO:0045830) |
| 0.9 |
3.7 |
GO:0032460 |
negative regulation of protein oligomerization(GO:0032460) negative regulation of protein homooligomerization(GO:0032463) |
| 0.9 |
3.7 |
GO:0007113 |
endomitotic cell cycle(GO:0007113) |
| 0.9 |
0.9 |
GO:0032201 |
telomere maintenance via semi-conservative replication(GO:0032201) |
| 0.9 |
0.9 |
GO:0060129 |
thyroid-stimulating hormone-secreting cell differentiation(GO:0060129) |
| 0.9 |
2.8 |
GO:0010838 |
positive regulation of keratinocyte proliferation(GO:0010838) |
| 0.9 |
12.0 |
GO:2000353 |
positive regulation of endothelial cell apoptotic process(GO:2000353) |
| 0.9 |
0.9 |
GO:1904354 |
negative regulation of telomere capping(GO:1904354) |
| 0.9 |
1.8 |
GO:0006931 |
substrate-dependent cell migration, cell attachment to substrate(GO:0006931) |
| 0.9 |
1.8 |
GO:0030997 |
regulation of centriole-centriole cohesion(GO:0030997) |
| 0.9 |
0.9 |
GO:0030225 |
macrophage differentiation(GO:0030225) |
| 0.9 |
6.4 |
GO:0001842 |
neural fold formation(GO:0001842) |
| 0.9 |
4.5 |
GO:0014886 |
transition between slow and fast fiber(GO:0014886) |
| 0.9 |
3.6 |
GO:1904565 |
response to 1-oleoyl-sn-glycerol 3-phosphate(GO:1904565) cellular response to 1-oleoyl-sn-glycerol 3-phosphate(GO:1904566) |
| 0.9 |
2.7 |
GO:0061181 |
regulation of chondrocyte development(GO:0061181) |
| 0.9 |
2.7 |
GO:0045738 |
negative regulation of DNA repair(GO:0045738) |
| 0.9 |
3.6 |
GO:1904380 |
endoplasmic reticulum mannose trimming(GO:1904380) |
| 0.9 |
1.8 |
GO:1901420 |
negative regulation of response to alcohol(GO:1901420) |
| 0.9 |
4.5 |
GO:0035331 |
negative regulation of hippo signaling(GO:0035331) |
| 0.9 |
0.9 |
GO:1903251 |
multi-ciliated epithelial cell differentiation(GO:1903251) |
| 0.9 |
2.7 |
GO:0006601 |
creatine biosynthetic process(GO:0006601) |
| 0.9 |
0.9 |
GO:0010664 |
negative regulation of striated muscle cell apoptotic process(GO:0010664) |
| 0.9 |
4.4 |
GO:0051572 |
negative regulation of histone H3-K4 methylation(GO:0051572) |
| 0.9 |
6.1 |
GO:0035567 |
non-canonical Wnt signaling pathway(GO:0035567) |
| 0.9 |
0.9 |
GO:0006059 |
hexitol metabolic process(GO:0006059) |
| 0.9 |
2.6 |
GO:0048698 |
negative regulation of collateral sprouting in absence of injury(GO:0048698) |
| 0.9 |
8.6 |
GO:0070940 |
dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
| 0.8 |
2.5 |
GO:0097278 |
complement-dependent cytotoxicity(GO:0097278) |
| 0.8 |
5.1 |
GO:0040037 |
negative regulation of fibroblast growth factor receptor signaling pathway(GO:0040037) |
| 0.8 |
4.2 |
GO:2001168 |
regulation of histone H2B ubiquitination(GO:2001166) positive regulation of histone H2B ubiquitination(GO:2001168) |
| 0.8 |
2.5 |
GO:0097461 |
ferric iron import(GO:0033216) ferric iron import into cell(GO:0097461) |
| 0.8 |
0.8 |
GO:0006933 |
negative regulation of cell adhesion involved in substrate-bound cell migration(GO:0006933) |
| 0.8 |
1.7 |
GO:1990705 |
cholangiocyte proliferation(GO:1990705) |
| 0.8 |
4.2 |
GO:0015867 |
ATP transport(GO:0015867) |
| 0.8 |
1.7 |
GO:0045343 |
MHC class I biosynthetic process(GO:0045341) regulation of MHC class I biosynthetic process(GO:0045343) positive regulation of MHC class I biosynthetic process(GO:0045345) |
| 0.8 |
3.3 |
GO:0003365 |
establishment of cell polarity involved in ameboidal cell migration(GO:0003365) |
| 0.8 |
5.8 |
GO:0061032 |
visceral serous pericardium development(GO:0061032) |
| 0.8 |
1.6 |
GO:0033088 |
negative regulation of immature T cell proliferation in thymus(GO:0033088) |
| 0.8 |
0.8 |
GO:0060741 |
prostate gland stromal morphogenesis(GO:0060741) |
| 0.8 |
4.9 |
GO:0003433 |
chondrocyte development involved in endochondral bone morphogenesis(GO:0003433) |
| 0.8 |
9.0 |
GO:0000183 |
chromatin silencing at rDNA(GO:0000183) |
| 0.8 |
5.7 |
GO:0016576 |
histone dephosphorylation(GO:0016576) |
| 0.8 |
1.6 |
GO:0003415 |
chondrocyte hypertrophy(GO:0003415) |
| 0.8 |
2.4 |
GO:0006590 |
thyroid hormone generation(GO:0006590) |
| 0.8 |
3.3 |
GO:0019355 |
nicotinamide nucleotide biosynthetic process from aspartate(GO:0019355) 'de novo' NAD biosynthetic process(GO:0034627) 'de novo' NAD biosynthetic process from aspartate(GO:0034628) |
| 0.8 |
2.4 |
GO:0061198 |
fungiform papilla formation(GO:0061198) |
| 0.8 |
9.7 |
GO:0030220 |
platelet formation(GO:0030220) |
| 0.8 |
3.2 |
GO:0016259 |
selenocysteine metabolic process(GO:0016259) |
| 0.8 |
3.2 |
GO:0006977 |
DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest(GO:0006977) |
| 0.8 |
0.8 |
GO:0035561 |
regulation of chromatin binding(GO:0035561) negative regulation of chromatin binding(GO:0035562) |
| 0.8 |
4.8 |
GO:0060017 |
parathyroid gland development(GO:0060017) |
| 0.8 |
17.4 |
GO:0006607 |
NLS-bearing protein import into nucleus(GO:0006607) |
| 0.8 |
1.6 |
GO:0060056 |
mammary gland involution(GO:0060056) |
| 0.8 |
11.1 |
GO:0070935 |
3'-UTR-mediated mRNA stabilization(GO:0070935) |
| 0.8 |
7.9 |
GO:0090557 |
establishment of endothelial intestinal barrier(GO:0090557) |
| 0.8 |
3.1 |
GO:0033314 |
mitotic DNA replication checkpoint(GO:0033314) |
| 0.8 |
2.3 |
GO:0009446 |
putrescine biosynthetic process(GO:0009446) |
| 0.8 |
1.6 |
GO:0032776 |
DNA methylation on cytosine within a CG sequence(GO:0010424) DNA methylation on cytosine(GO:0032776) |
| 0.8 |
3.1 |
GO:1990253 |
cellular response to leucine starvation(GO:1990253) |
| 0.8 |
3.1 |
GO:1903265 |
positive regulation of tumor necrosis factor-mediated signaling pathway(GO:1903265) |
| 0.8 |
9.3 |
GO:0071364 |
cellular response to epidermal growth factor stimulus(GO:0071364) |
| 0.8 |
0.8 |
GO:0042059 |
negative regulation of epidermal growth factor receptor signaling pathway(GO:0042059) negative regulation of ERBB signaling pathway(GO:1901185) |
| 0.8 |
1.5 |
GO:0033184 |
positive regulation of histone ubiquitination(GO:0033184) |
| 0.8 |
3.1 |
GO:1990414 |
replication-born double-strand break repair via sister chromatid exchange(GO:1990414) |
| 0.8 |
5.4 |
GO:0002315 |
marginal zone B cell differentiation(GO:0002315) |
| 0.8 |
1.5 |
GO:0003161 |
cardiac conduction system development(GO:0003161) |
| 0.8 |
6.1 |
GO:0043046 |
DNA methylation involved in gamete generation(GO:0043046) |
| 0.8 |
2.3 |
GO:0044339 |
canonical Wnt signaling pathway involved in osteoblast differentiation(GO:0044339) |
| 0.8 |
3.8 |
GO:0043353 |
enucleate erythrocyte differentiation(GO:0043353) |
| 0.8 |
0.8 |
GO:0046628 |
positive regulation of insulin receptor signaling pathway(GO:0046628) |
| 0.8 |
2.3 |
GO:0018298 |
protein-chromophore linkage(GO:0018298) |
| 0.8 |
0.8 |
GO:0060011 |
Sertoli cell proliferation(GO:0060011) |
| 0.8 |
0.8 |
GO:0051533 |
positive regulation of NFAT protein import into nucleus(GO:0051533) |
| 0.8 |
3.0 |
GO:1900220 |
semaphorin-plexin signaling pathway involved in bone trabecula morphogenesis(GO:1900220) |
| 0.8 |
3.8 |
GO:0075525 |
viral translational termination-reinitiation(GO:0075525) |
| 0.8 |
8.3 |
GO:0006000 |
fructose metabolic process(GO:0006000) |
| 0.7 |
3.0 |
GO:0006438 |
valyl-tRNA aminoacylation(GO:0006438) |
| 0.7 |
0.7 |
GO:0070100 |
negative regulation of chemokine-mediated signaling pathway(GO:0070100) |
| 0.7 |
3.7 |
GO:0060763 |
mammary duct terminal end bud growth(GO:0060763) |
| 0.7 |
4.5 |
GO:0035459 |
cargo loading into vesicle(GO:0035459) |
| 0.7 |
5.2 |
GO:0048702 |
embryonic neurocranium morphogenesis(GO:0048702) |
| 0.7 |
1.5 |
GO:0000720 |
pyrimidine dimer repair by nucleotide-excision repair(GO:0000720) |
| 0.7 |
3.0 |
GO:0097152 |
mesenchymal cell apoptotic process(GO:0097152) |
| 0.7 |
2.2 |
GO:0042908 |
xenobiotic transport(GO:0042908) |
| 0.7 |
12.6 |
GO:0006346 |
methylation-dependent chromatin silencing(GO:0006346) |
| 0.7 |
2.2 |
GO:1902396 |
protein localization to bicellular tight junction(GO:1902396) |
| 0.7 |
0.7 |
GO:0010831 |
positive regulation of myotube differentiation(GO:0010831) |
| 0.7 |
2.2 |
GO:0042447 |
hormone catabolic process(GO:0042447) |
| 0.7 |
6.6 |
GO:0032075 |
positive regulation of nuclease activity(GO:0032075) |
| 0.7 |
2.2 |
GO:2000418 |
positive regulation of eosinophil migration(GO:2000418) |
| 0.7 |
0.7 |
GO:0060399 |
positive regulation of growth hormone receptor signaling pathway(GO:0060399) |
| 0.7 |
2.2 |
GO:0002408 |
myeloid dendritic cell chemotaxis(GO:0002408) |
| 0.7 |
2.2 |
GO:1904274 |
tricellular tight junction assembly(GO:1904274) |
| 0.7 |
0.7 |
GO:0071047 |
nuclear polyadenylation-dependent mRNA catabolic process(GO:0071042) polyadenylation-dependent mRNA catabolic process(GO:0071047) |
| 0.7 |
0.7 |
GO:0044351 |
macropinocytosis(GO:0044351) |
| 0.7 |
1.5 |
GO:0010519 |
negative regulation of phospholipase activity(GO:0010519) |
| 0.7 |
6.5 |
GO:0043568 |
positive regulation of insulin-like growth factor receptor signaling pathway(GO:0043568) |
| 0.7 |
7.9 |
GO:0032211 |
negative regulation of telomere maintenance via telomerase(GO:0032211) |
| 0.7 |
1.4 |
GO:1903519 |
apoptotic process involved in mammary gland involution(GO:0060057) positive regulation of apoptotic process involved in mammary gland involution(GO:0060058) positive regulation of apoptotic process involved in morphogenesis(GO:1902339) regulation of mammary gland involution(GO:1903519) positive regulation of mammary gland involution(GO:1903521) positive regulation of apoptotic process involved in development(GO:1904747) |
| 0.7 |
0.7 |
GO:0006296 |
nucleotide-excision repair, DNA incision, 5'-to lesion(GO:0006296) |
| 0.7 |
2.1 |
GO:0072675 |
osteoclast fusion(GO:0072675) |
| 0.7 |
1.4 |
GO:0006271 |
DNA strand elongation involved in DNA replication(GO:0006271) |
| 0.7 |
5.7 |
GO:0006104 |
succinyl-CoA metabolic process(GO:0006104) |
| 0.7 |
10.0 |
GO:0038063 |
collagen-activated tyrosine kinase receptor signaling pathway(GO:0038063) |
| 0.7 |
1.4 |
GO:0090274 |
positive regulation of somatostatin secretion(GO:0090274) |
| 0.7 |
0.7 |
GO:0030046 |
parallel actin filament bundle assembly(GO:0030046) |
| 0.7 |
3.5 |
GO:0043586 |
tongue development(GO:0043586) |
| 0.7 |
2.1 |
GO:0006166 |
purine ribonucleoside salvage(GO:0006166) |
| 0.7 |
0.7 |
GO:0070365 |
hepatocyte differentiation(GO:0070365) |
| 0.7 |
2.8 |
GO:0060539 |
diaphragm development(GO:0060539) |
| 0.7 |
2.1 |
GO:0033632 |
regulation of cell-cell adhesion mediated by integrin(GO:0033632) |
| 0.7 |
2.8 |
GO:0090237 |
regulation of arachidonic acid secretion(GO:0090237) positive regulation of arachidonic acid secretion(GO:0090238) |
| 0.7 |
2.1 |
GO:0048312 |
intracellular distribution of mitochondria(GO:0048312) |
| 0.7 |
6.9 |
GO:0044872 |
lipoprotein transport(GO:0042953) lipoprotein localization(GO:0044872) |
| 0.7 |
0.7 |
GO:0070914 |
UV-damage excision repair(GO:0070914) |
| 0.7 |
2.1 |
GO:0051352 |
negative regulation of ligase activity(GO:0051352) negative regulation of ubiquitin-protein transferase activity(GO:0051444) |
| 0.7 |
6.9 |
GO:0006085 |
acetyl-CoA biosynthetic process(GO:0006085) |
| 0.7 |
2.7 |
GO:0046909 |
intermembrane transport(GO:0046909) |
| 0.7 |
0.7 |
GO:0034140 |
negative regulation of toll-like receptor 3 signaling pathway(GO:0034140) |
| 0.7 |
4.8 |
GO:0035563 |
positive regulation of chromatin binding(GO:0035563) |
| 0.7 |
8.8 |
GO:0040034 |
regulation of development, heterochronic(GO:0040034) |
| 0.7 |
2.0 |
GO:0021523 |
somatic motor neuron differentiation(GO:0021523) |
| 0.7 |
8.7 |
GO:0051451 |
myoblast migration(GO:0051451) |
| 0.7 |
1.3 |
GO:0018076 |
N-terminal peptidyl-lysine acetylation(GO:0018076) |
| 0.7 |
2.0 |
GO:0030916 |
otic vesicle formation(GO:0030916) |
| 0.7 |
2.0 |
GO:0060800 |
regulation of cell differentiation involved in embryonic placenta development(GO:0060800) |
| 0.7 |
2.0 |
GO:1903048 |
regulation of acetylcholine-gated cation channel activity(GO:1903048) |
| 0.7 |
7.3 |
GO:0000578 |
embryonic axis specification(GO:0000578) |
| 0.7 |
23.8 |
GO:0006284 |
base-excision repair(GO:0006284) |
| 0.7 |
2.0 |
GO:0010814 |
substance P catabolic process(GO:0010814) calcitonin catabolic process(GO:0010816) endothelin maturation(GO:0034959) |
| 0.7 |
3.9 |
GO:0098535 |
de novo centriole assembly(GO:0098535) |
| 0.7 |
3.9 |
GO:0002523 |
leukocyte migration involved in inflammatory response(GO:0002523) |
| 0.7 |
0.7 |
GO:0071169 |
establishment of protein localization to chromatin(GO:0071169) |
| 0.6 |
2.6 |
GO:0008635 |
activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c(GO:0008635) |
| 0.6 |
1.9 |
GO:0014835 |
myoblast differentiation involved in skeletal muscle regeneration(GO:0014835) |
| 0.6 |
3.2 |
GO:1904948 |
midbrain dopaminergic neuron differentiation(GO:1904948) |
| 0.6 |
2.5 |
GO:0035188 |
blastocyst hatching(GO:0001835) hatching(GO:0035188) organism emergence from protective structure(GO:0071684) |
| 0.6 |
1.9 |
GO:0015772 |
disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
| 0.6 |
4.4 |
GO:0070458 |
detoxification of nitrogen compound(GO:0051410) cellular detoxification of nitrogen compound(GO:0070458) |
| 0.6 |
3.1 |
GO:0016540 |
protein autoprocessing(GO:0016540) |
| 0.6 |
1.3 |
GO:0019405 |
alditol catabolic process(GO:0019405) |
| 0.6 |
11.3 |
GO:2000052 |
positive regulation of non-canonical Wnt signaling pathway(GO:2000052) |
| 0.6 |
1.9 |
GO:0090071 |
negative regulation of ribosome biogenesis(GO:0090071) |
| 0.6 |
1.9 |
GO:0006578 |
amino-acid betaine biosynthetic process(GO:0006578) |
| 0.6 |
2.5 |
GO:0015705 |
iodide transport(GO:0015705) |
| 0.6 |
1.2 |
GO:0001787 |
natural killer cell proliferation(GO:0001787) |
| 0.6 |
5.5 |
GO:0032332 |
positive regulation of chondrocyte differentiation(GO:0032332) |
| 0.6 |
0.6 |
GO:0060535 |
trachea cartilage morphogenesis(GO:0060535) |
| 0.6 |
1.2 |
GO:0007290 |
spermatid nucleus elongation(GO:0007290) |
| 0.6 |
5.5 |
GO:0090344 |
negative regulation of cell aging(GO:0090344) |
| 0.6 |
0.6 |
GO:0000722 |
telomere maintenance via recombination(GO:0000722) |
| 0.6 |
0.6 |
GO:0061626 |
pharyngeal arch artery morphogenesis(GO:0061626) |
| 0.6 |
4.9 |
GO:0008343 |
adult feeding behavior(GO:0008343) |
| 0.6 |
3.6 |
GO:0036066 |
protein O-linked fucosylation(GO:0036066) |
| 0.6 |
13.7 |
GO:0008608 |
attachment of spindle microtubules to kinetochore(GO:0008608) |
| 0.6 |
1.8 |
GO:0009263 |
deoxyribonucleotide biosynthetic process(GO:0009263) |
| 0.6 |
2.4 |
GO:1903300 |
negative regulation of glucokinase activity(GO:0033132) negative regulation of hexokinase activity(GO:1903300) |
| 0.6 |
8.9 |
GO:0010569 |
regulation of double-strand break repair via homologous recombination(GO:0010569) |
| 0.6 |
1.8 |
GO:1904685 |
positive regulation of metalloendopeptidase activity(GO:1904685) |
| 0.6 |
1.8 |
GO:0089700 |
protein kinase D signaling(GO:0089700) |
| 0.6 |
4.1 |
GO:0000103 |
sulfate assimilation(GO:0000103) |
| 0.6 |
0.6 |
GO:1904154 |
positive regulation of retrograde protein transport, ER to cytosol(GO:1904154) |
| 0.6 |
4.1 |
GO:0046607 |
positive regulation of centrosome cycle(GO:0046607) |
| 0.6 |
2.9 |
GO:2000491 |
positive regulation of hepatic stellate cell activation(GO:2000491) |
| 0.6 |
14.1 |
GO:0043171 |
peptide catabolic process(GO:0043171) |
| 0.6 |
0.6 |
GO:0032747 |
positive regulation of interleukin-23 production(GO:0032747) |
| 0.6 |
0.6 |
GO:0046166 |
glyceraldehyde-3-phosphate biosynthetic process(GO:0046166) |
| 0.6 |
1.7 |
GO:0072718 |
response to cisplatin(GO:0072718) |
| 0.6 |
4.6 |
GO:0030538 |
embryonic genitalia morphogenesis(GO:0030538) |
| 0.6 |
1.7 |
GO:0070535 |
histone H2A K63-linked ubiquitination(GO:0070535) |
| 0.6 |
0.6 |
GO:0042730 |
fibrinolysis(GO:0042730) |
| 0.6 |
0.6 |
GO:0070827 |
chromatin maintenance(GO:0070827) |
| 0.6 |
5.1 |
GO:0006450 |
regulation of translational fidelity(GO:0006450) |
| 0.6 |
3.4 |
GO:0060068 |
vagina development(GO:0060068) |
| 0.6 |
0.6 |
GO:0003207 |
cardiac chamber formation(GO:0003207) cardiac ventricle formation(GO:0003211) |
| 0.6 |
1.7 |
GO:0021691 |
cerebellar Purkinje cell layer maturation(GO:0021691) |
| 0.6 |
5.7 |
GO:0045899 |
positive regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0045899) |
| 0.6 |
1.7 |
GO:0060391 |
positive regulation of SMAD protein import into nucleus(GO:0060391) |
| 0.6 |
10.7 |
GO:0043968 |
histone H2A acetylation(GO:0043968) |
| 0.6 |
2.2 |
GO:0042360 |
vitamin E metabolic process(GO:0042360) |
| 0.6 |
5.1 |
GO:0048251 |
elastic fiber assembly(GO:0048251) |
| 0.6 |
6.7 |
GO:0048096 |
chromatin-mediated maintenance of transcription(GO:0048096) |
| 0.6 |
1.7 |
GO:0030210 |
heparin biosynthetic process(GO:0030210) |
| 0.6 |
6.1 |
GO:0060707 |
trophoblast giant cell differentiation(GO:0060707) |
| 0.6 |
2.8 |
GO:1904995 |
negative regulation of leukocyte adhesion to vascular endothelial cell(GO:1904995) |
| 0.6 |
1.1 |
GO:0040038 |
polar body extrusion after meiotic divisions(GO:0040038) |
| 0.6 |
0.6 |
GO:0006551 |
leucine metabolic process(GO:0006551) |
| 0.6 |
9.9 |
GO:1902857 |
positive regulation of nonmotile primary cilium assembly(GO:1902857) |
| 0.5 |
0.5 |
GO:0036118 |
hyaluranon cable assembly(GO:0036118) regulation of hyaluranon cable assembly(GO:1900104) positive regulation of hyaluranon cable assembly(GO:1900106) |
| 0.5 |
3.8 |
GO:0031053 |
primary miRNA processing(GO:0031053) |
| 0.5 |
2.7 |
GO:0043983 |
histone H4-K12 acetylation(GO:0043983) |
| 0.5 |
1.6 |
GO:0042505 |
tyrosine phosphorylation of Stat6 protein(GO:0042505) regulation of tyrosine phosphorylation of Stat6 protein(GO:0042525) |
| 0.5 |
3.2 |
GO:0010528 |
regulation of transposition(GO:0010528) negative regulation of transposition(GO:0010529) |
| 0.5 |
2.1 |
GO:0001880 |
Mullerian duct regression(GO:0001880) |
| 0.5 |
1.1 |
GO:0042414 |
epinephrine metabolic process(GO:0042414) |
| 0.5 |
2.1 |
GO:1903624 |
regulation of apoptotic DNA fragmentation(GO:1902510) regulation of DNA catabolic process(GO:1903624) |
| 0.5 |
18.5 |
GO:0000387 |
spliceosomal snRNP assembly(GO:0000387) |
| 0.5 |
0.5 |
GO:1902166 |
negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:1902166) |
| 0.5 |
1.6 |
GO:0035262 |
gonad morphogenesis(GO:0035262) |
| 0.5 |
1.1 |
GO:0042474 |
middle ear morphogenesis(GO:0042474) |
| 0.5 |
8.9 |
GO:0043248 |
proteasome assembly(GO:0043248) |
| 0.5 |
2.6 |
GO:0010032 |
meiotic chromosome condensation(GO:0010032) |
| 0.5 |
7.3 |
GO:1904293 |
negative regulation of ERAD pathway(GO:1904293) |
| 0.5 |
0.5 |
GO:0036091 |
positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0036091) |
| 0.5 |
2.1 |
GO:0038128 |
ERBB2 signaling pathway(GO:0038128) |
| 0.5 |
1.0 |
GO:0034729 |
histone H3-K79 methylation(GO:0034729) |
| 0.5 |
3.1 |
GO:0015074 |
DNA integration(GO:0015074) |
| 0.5 |
2.6 |
GO:0060430 |
lung saccule development(GO:0060430) |
| 0.5 |
1.0 |
GO:0090187 |
positive regulation of pancreatic juice secretion(GO:0090187) |
| 0.5 |
2.0 |
GO:0033631 |
cell-cell adhesion mediated by integrin(GO:0033631) |
| 0.5 |
1.0 |
GO:0003100 |
regulation of systemic arterial blood pressure by endothelin(GO:0003100) |
| 0.5 |
3.0 |
GO:0048563 |
post-embryonic organ morphogenesis(GO:0048563) |
| 0.5 |
3.5 |
GO:0015675 |
nickel cation transport(GO:0015675) |
| 0.5 |
6.0 |
GO:0006388 |
tRNA splicing, via endonucleolytic cleavage and ligation(GO:0006388) |
| 0.5 |
0.5 |
GO:0010803 |
regulation of tumor necrosis factor-mediated signaling pathway(GO:0010803) negative regulation of tumor necrosis factor-mediated signaling pathway(GO:0010804) |
| 0.5 |
1.5 |
GO:2000348 |
regulation of CD40 signaling pathway(GO:2000348) |
| 0.5 |
3.0 |
GO:0060736 |
prostate gland growth(GO:0060736) |
| 0.5 |
2.0 |
GO:0006309 |
apoptotic DNA fragmentation(GO:0006309) |
| 0.5 |
2.5 |
GO:0032472 |
Golgi calcium ion transport(GO:0032472) |
| 0.5 |
7.5 |
GO:0000303 |
response to superoxide(GO:0000303) |
| 0.5 |
2.0 |
GO:0043490 |
malate-aspartate shuttle(GO:0043490) |
| 0.5 |
2.5 |
GO:0043569 |
negative regulation of insulin-like growth factor receptor signaling pathway(GO:0043569) |
| 0.5 |
4.0 |
GO:0043923 |
positive regulation by host of viral transcription(GO:0043923) |
| 0.5 |
0.5 |
GO:0010637 |
negative regulation of mitochondrial fusion(GO:0010637) |
| 0.5 |
4.9 |
GO:0060065 |
uterus development(GO:0060065) |
| 0.5 |
0.5 |
GO:2000393 |
negative regulation of lamellipodium morphogenesis(GO:2000393) |
| 0.5 |
1.5 |
GO:0035426 |
extracellular matrix-cell signaling(GO:0035426) |
| 0.5 |
0.5 |
GO:0007227 |
signal transduction downstream of smoothened(GO:0007227) |
| 0.5 |
1.5 |
GO:0007406 |
negative regulation of neuroblast proliferation(GO:0007406) |
| 0.5 |
2.9 |
GO:0009235 |
cobalamin metabolic process(GO:0009235) |
| 0.5 |
1.0 |
GO:0002309 |
T cell proliferation involved in immune response(GO:0002309) |
| 0.5 |
1.4 |
GO:0070307 |
lens fiber cell development(GO:0070307) |
| 0.5 |
1.0 |
GO:0060743 |
epithelial cell maturation involved in prostate gland development(GO:0060743) |
| 0.5 |
1.0 |
GO:0030222 |
eosinophil differentiation(GO:0030222) |
| 0.5 |
1.4 |
GO:0070459 |
prolactin secretion(GO:0070459) |
| 0.5 |
1.9 |
GO:0046294 |
formaldehyde catabolic process(GO:0046294) |
| 0.5 |
1.0 |
GO:0061013 |
regulation of mRNA catabolic process(GO:0061013) positive regulation of mRNA catabolic process(GO:0061014) |
| 0.5 |
0.5 |
GO:2000628 |
regulation of miRNA metabolic process(GO:2000628) |
| 0.5 |
3.8 |
GO:0003062 |
regulation of heart rate by chemical signal(GO:0003062) |
| 0.5 |
4.3 |
GO:0038166 |
angiotensin-activated signaling pathway(GO:0038166) |
| 0.5 |
6.2 |
GO:0007530 |
sex determination(GO:0007530) |
| 0.5 |
0.5 |
GO:0043652 |
engulfment of apoptotic cell(GO:0043652) |
| 0.5 |
0.9 |
GO:0060872 |
semicircular canal development(GO:0060872) |
| 0.5 |
14.1 |
GO:0034723 |
DNA replication-dependent nucleosome assembly(GO:0006335) DNA replication-dependent nucleosome organization(GO:0034723) |
| 0.5 |
0.9 |
GO:0036075 |
endochondral ossification(GO:0001958) replacement ossification(GO:0036075) |
| 0.5 |
0.9 |
GO:2000620 |
positive regulation of histone H4-K16 acetylation(GO:2000620) |
| 0.5 |
1.4 |
GO:0038203 |
TORC2 signaling(GO:0038203) |
| 0.5 |
7.9 |
GO:0016180 |
snRNA processing(GO:0016180) |
| 0.5 |
2.8 |
GO:0010719 |
negative regulation of epithelial to mesenchymal transition(GO:0010719) |
| 0.5 |
2.3 |
GO:0060330 |
regulation of response to interferon-gamma(GO:0060330) |
| 0.5 |
1.4 |
GO:0010940 |
positive regulation of necrotic cell death(GO:0010940) |
| 0.5 |
0.5 |
GO:0006776 |
vitamin A metabolic process(GO:0006776) |
| 0.5 |
1.8 |
GO:0001711 |
endodermal cell fate commitment(GO:0001711) |
| 0.5 |
4.5 |
GO:0046036 |
CTP biosynthetic process(GO:0006241) CTP metabolic process(GO:0046036) |
| 0.5 |
2.7 |
GO:0032929 |
negative regulation of superoxide anion generation(GO:0032929) |
| 0.4 |
2.7 |
GO:1902231 |
positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902231) |
| 0.4 |
0.4 |
GO:2000738 |
positive regulation of stem cell differentiation(GO:2000738) |
| 0.4 |
4.0 |
GO:0015721 |
bile acid and bile salt transport(GO:0015721) |
| 0.4 |
0.9 |
GO:0051599 |
response to hydrostatic pressure(GO:0051599) |
| 0.4 |
3.6 |
GO:0035542 |
regulation of SNARE complex assembly(GO:0035542) |
| 0.4 |
0.9 |
GO:0006610 |
ribosomal protein import into nucleus(GO:0006610) |
| 0.4 |
0.9 |
GO:1903377 |
negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903377) |
| 0.4 |
3.1 |
GO:0035413 |
positive regulation of catenin import into nucleus(GO:0035413) |
| 0.4 |
1.8 |
GO:0031509 |
telomeric heterochromatin assembly(GO:0031509) negative regulation of chromosome condensation(GO:1902340) |
| 0.4 |
1.3 |
GO:0061110 |
dense core granule biogenesis(GO:0061110) regulation of dense core granule biogenesis(GO:2000705) |
| 0.4 |
0.4 |
GO:0071600 |
otic vesicle morphogenesis(GO:0071600) |
| 0.4 |
0.9 |
GO:0061101 |
neuroendocrine cell differentiation(GO:0061101) |
| 0.4 |
0.4 |
GO:0034035 |
purine ribonucleoside bisphosphate metabolic process(GO:0034035) |
| 0.4 |
0.9 |
GO:0003376 |
sphingosine-1-phosphate signaling pathway(GO:0003376) sphingolipid mediated signaling pathway(GO:0090520) |
| 0.4 |
0.4 |
GO:0036353 |
histone H2A-K119 monoubiquitination(GO:0036353) |
| 0.4 |
14.3 |
GO:0001738 |
morphogenesis of a polarized epithelium(GO:0001738) |
| 0.4 |
3.0 |
GO:0060340 |
positive regulation of type I interferon-mediated signaling pathway(GO:0060340) |
| 0.4 |
8.2 |
GO:0009299 |
mRNA transcription(GO:0009299) |
| 0.4 |
7.7 |
GO:0000188 |
inactivation of MAPK activity(GO:0000188) |
| 0.4 |
4.3 |
GO:0019262 |
N-acetylneuraminate catabolic process(GO:0019262) |
| 0.4 |
1.7 |
GO:0010452 |
histone H3-K36 methylation(GO:0010452) |
| 0.4 |
4.3 |
GO:0006825 |
copper ion transport(GO:0006825) |
| 0.4 |
7.7 |
GO:0000028 |
ribosomal small subunit assembly(GO:0000028) |
| 0.4 |
0.4 |
GO:0046013 |
T cell homeostatic proliferation(GO:0001777) regulation of T cell homeostatic proliferation(GO:0046013) |
| 0.4 |
4.7 |
GO:0030261 |
chromosome condensation(GO:0030261) |
| 0.4 |
1.7 |
GO:0033601 |
positive regulation of mammary gland epithelial cell proliferation(GO:0033601) |
| 0.4 |
4.7 |
GO:0046784 |
viral mRNA export from host cell nucleus(GO:0046784) |
| 0.4 |
0.4 |
GO:0031914 |
negative regulation of synaptic plasticity(GO:0031914) |
| 0.4 |
3.0 |
GO:0006924 |
activation-induced cell death of T cells(GO:0006924) |
| 0.4 |
0.4 |
GO:0060528 |
secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development(GO:0060528) |
| 0.4 |
2.1 |
GO:0019471 |
4-hydroxyproline metabolic process(GO:0019471) |
| 0.4 |
1.3 |
GO:0031120 |
snRNA pseudouridine synthesis(GO:0031120) |
| 0.4 |
3.8 |
GO:0060441 |
epithelial tube branching involved in lung morphogenesis(GO:0060441) |
| 0.4 |
2.9 |
GO:0035414 |
negative regulation of catenin import into nucleus(GO:0035414) |
| 0.4 |
7.1 |
GO:0045116 |
protein neddylation(GO:0045116) |
| 0.4 |
5.0 |
GO:0007141 |
male meiosis I(GO:0007141) |
| 0.4 |
1.2 |
GO:0051182 |
coenzyme transport(GO:0051182) |
| 0.4 |
0.4 |
GO:0003245 |
cardiac muscle tissue growth involved in heart morphogenesis(GO:0003245) |
| 0.4 |
1.2 |
GO:0002082 |
regulation of oxidative phosphorylation(GO:0002082) |
| 0.4 |
1.2 |
GO:0000350 |
generation of catalytic spliceosome for second transesterification step(GO:0000350) |
| 0.4 |
1.7 |
GO:1905049 |
negative regulation of metalloendopeptidase activity(GO:1904684) negative regulation of metallopeptidase activity(GO:1905049) |
| 0.4 |
2.1 |
GO:0050434 |
positive regulation of viral transcription(GO:0050434) |
| 0.4 |
1.2 |
GO:0001869 |
regulation of complement activation, lectin pathway(GO:0001868) negative regulation of complement activation, lectin pathway(GO:0001869) |
| 0.4 |
0.4 |
GO:1901187 |
regulation of ephrin receptor signaling pathway(GO:1901187) |
| 0.4 |
1.2 |
GO:0031860 |
telomeric 3' overhang formation(GO:0031860) |
| 0.4 |
1.2 |
GO:0046602 |
regulation of mitotic centrosome separation(GO:0046602) |
| 0.4 |
4.9 |
GO:0010718 |
positive regulation of epithelial to mesenchymal transition(GO:0010718) |
| 0.4 |
1.6 |
GO:1903204 |
negative regulation of oxidative stress-induced neuron death(GO:1903204) |
| 0.4 |
3.7 |
GO:0034377 |
plasma lipoprotein particle assembly(GO:0034377) |
| 0.4 |
1.2 |
GO:2000819 |
regulation of nucleotide-excision repair(GO:2000819) |
| 0.4 |
2.4 |
GO:0006452 |
translational frameshifting(GO:0006452) positive regulation of translational termination(GO:0045905) |
| 0.4 |
1.2 |
GO:2000616 |
negative regulation of histone H3-K9 acetylation(GO:2000616) |
| 0.4 |
1.6 |
GO:0015888 |
thiamine transport(GO:0015888) |
| 0.4 |
0.8 |
GO:0045650 |
negative regulation of macrophage differentiation(GO:0045650) |
| 0.4 |
1.2 |
GO:0003148 |
outflow tract septum morphogenesis(GO:0003148) |
| 0.4 |
0.8 |
GO:0050995 |
negative regulation of lipid catabolic process(GO:0050995) |
| 0.4 |
7.2 |
GO:0046039 |
GTP metabolic process(GO:0046039) |
| 0.4 |
1.2 |
GO:0010724 |
regulation of definitive erythrocyte differentiation(GO:0010724) |
| 0.4 |
2.3 |
GO:0018195 |
peptidyl-arginine modification(GO:0018195) |
| 0.4 |
1.2 |
GO:1904211 |
membrane protein proteolysis involved in retrograde protein transport, ER to cytosol(GO:1904211) |
| 0.4 |
1.6 |
GO:0031145 |
anaphase-promoting complex-dependent catabolic process(GO:0031145) |
| 0.4 |
0.4 |
GO:1902414 |
protein localization to cell junction(GO:1902414) |
| 0.4 |
3.5 |
GO:0035116 |
embryonic hindlimb morphogenesis(GO:0035116) |
| 0.4 |
3.1 |
GO:0034724 |
DNA replication-independent nucleosome assembly(GO:0006336) DNA replication-independent nucleosome organization(GO:0034724) |
| 0.4 |
0.8 |
GO:0000389 |
mRNA 3'-splice site recognition(GO:0000389) |
| 0.4 |
4.6 |
GO:0000463 |
maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000463) |
| 0.4 |
1.9 |
GO:1903690 |
negative regulation of wound healing, spreading of epidermal cells(GO:1903690) |
| 0.4 |
1.9 |
GO:0030263 |
apoptotic chromosome condensation(GO:0030263) |
| 0.4 |
0.8 |
GO:2000380 |
regulation of mesoderm development(GO:2000380) |
| 0.4 |
1.5 |
GO:2000675 |
negative regulation of type B pancreatic cell apoptotic process(GO:2000675) |
| 0.4 |
4.2 |
GO:2001241 |
positive regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001241) |
| 0.4 |
0.4 |
GO:0046639 |
negative regulation of CD4-positive, alpha-beta T cell differentiation(GO:0043371) negative regulation of T-helper cell differentiation(GO:0045623) negative regulation of alpha-beta T cell differentiation(GO:0046639) negative regulation of CD4-positive, alpha-beta T cell activation(GO:2000515) |
| 0.4 |
1.1 |
GO:0015960 |
diadenosine polyphosphate biosynthetic process(GO:0015960) diadenosine tetraphosphate metabolic process(GO:0015965) diadenosine tetraphosphate biosynthetic process(GO:0015966) |
| 0.4 |
0.4 |
GO:0046826 |
negative regulation of protein export from nucleus(GO:0046826) |
| 0.4 |
5.3 |
GO:0016973 |
poly(A)+ mRNA export from nucleus(GO:0016973) |
| 0.4 |
0.8 |
GO:0048853 |
forebrain morphogenesis(GO:0048853) |
| 0.4 |
2.7 |
GO:0021511 |
spinal cord patterning(GO:0021511) |
| 0.4 |
2.7 |
GO:0001779 |
natural killer cell differentiation(GO:0001779) |
| 0.4 |
0.4 |
GO:0060455 |
regulation of gastric acid secretion(GO:0060453) negative regulation of gastric acid secretion(GO:0060455) |
| 0.4 |
0.4 |
GO:0072498 |
embryonic skeletal joint development(GO:0072498) |
| 0.4 |
0.7 |
GO:0061052 |
negative regulation of cell growth involved in cardiac muscle cell development(GO:0061052) |
| 0.4 |
1.9 |
GO:0042256 |
mature ribosome assembly(GO:0042256) |
| 0.4 |
0.4 |
GO:0035973 |
aggrephagy(GO:0035973) |
| 0.4 |
1.5 |
GO:0051387 |
negative regulation of neurotrophin TRK receptor signaling pathway(GO:0051387) |
| 0.4 |
13.7 |
GO:0051028 |
mRNA transport(GO:0051028) |
| 0.4 |
0.7 |
GO:0015938 |
coenzyme A catabolic process(GO:0015938) nucleoside bisphosphate catabolic process(GO:0033869) ribonucleoside bisphosphate catabolic process(GO:0034031) purine nucleoside bisphosphate catabolic process(GO:0034034) |
| 0.4 |
3.0 |
GO:0033148 |
positive regulation of intracellular estrogen receptor signaling pathway(GO:0033148) |
| 0.4 |
0.7 |
GO:0046666 |
retinal cell programmed cell death(GO:0046666) |
| 0.4 |
6.6 |
GO:0007099 |
centriole replication(GO:0007099) |
| 0.4 |
0.4 |
GO:0065004 |
protein-DNA complex assembly(GO:0065004) |
| 0.4 |
0.7 |
GO:0061072 |
iris morphogenesis(GO:0061072) |
| 0.4 |
2.9 |
GO:0010226 |
response to lithium ion(GO:0010226) |
| 0.4 |
1.1 |
GO:0030647 |
polyketide metabolic process(GO:0030638) aminoglycoside antibiotic metabolic process(GO:0030647) daunorubicin metabolic process(GO:0044597) doxorubicin metabolic process(GO:0044598) |
| 0.4 |
1.5 |
GO:1904491 |
protein localization to ciliary transition zone(GO:1904491) |
| 0.4 |
1.8 |
GO:1901341 |
activation of store-operated calcium channel activity(GO:0032237) positive regulation of store-operated calcium channel activity(GO:1901341) |
| 0.4 |
2.2 |
GO:0016446 |
somatic hypermutation of immunoglobulin genes(GO:0016446) |
| 0.4 |
4.7 |
GO:0051044 |
positive regulation of membrane protein ectodomain proteolysis(GO:0051044) |
| 0.4 |
1.1 |
GO:0006434 |
seryl-tRNA aminoacylation(GO:0006434) |
| 0.4 |
0.4 |
GO:0006264 |
mitochondrial DNA replication(GO:0006264) |
| 0.4 |
3.2 |
GO:0018065 |
protein-cofactor linkage(GO:0018065) |
| 0.4 |
1.1 |
GO:0003349 |
epicardium-derived cardiac endothelial cell differentiation(GO:0003349) |
| 0.4 |
1.1 |
GO:0051490 |
negative regulation of filopodium assembly(GO:0051490) |
| 0.3 |
3.5 |
GO:0018126 |
protein hydroxylation(GO:0018126) |
| 0.3 |
0.7 |
GO:0075522 |
IRES-dependent viral translational initiation(GO:0075522) |
| 0.3 |
2.1 |
GO:0032494 |
response to peptidoglycan(GO:0032494) |
| 0.3 |
1.0 |
GO:0006597 |
spermine biosynthetic process(GO:0006597) |
| 0.3 |
4.2 |
GO:0030953 |
astral microtubule organization(GO:0030953) |
| 0.3 |
0.3 |
GO:0048318 |
axial mesoderm development(GO:0048318) |
| 0.3 |
14.5 |
GO:0000725 |
double-strand break repair via homologous recombination(GO:0000724) recombinational repair(GO:0000725) |
| 0.3 |
2.1 |
GO:0045974 |
miRNA mediated inhibition of translation(GO:0035278) negative regulation of translation, ncRNA-mediated(GO:0040033) regulation of translation, ncRNA-mediated(GO:0045974) |
| 0.3 |
1.4 |
GO:0055099 |
response to high density lipoprotein particle(GO:0055099) |
| 0.3 |
0.7 |
GO:0032760 |
positive regulation of tumor necrosis factor production(GO:0032760) positive regulation of tumor necrosis factor superfamily cytokine production(GO:1903557) |
| 0.3 |
1.4 |
GO:0071475 |
cellular hyperosmotic salinity response(GO:0071475) |
| 0.3 |
1.0 |
GO:0031424 |
keratinization(GO:0031424) |
| 0.3 |
1.0 |
GO:0042097 |
interleukin-4 biosynthetic process(GO:0042097) regulation of interleukin-4 biosynthetic process(GO:0045402) positive regulation of interleukin-4 biosynthetic process(GO:0045404) |
| 0.3 |
3.1 |
GO:0048672 |
positive regulation of collateral sprouting(GO:0048672) |
| 0.3 |
0.3 |
GO:0048239 |
negative regulation of DNA recombination at telomere(GO:0048239) regulation of DNA recombination at telomere(GO:0072695) |
| 0.3 |
1.7 |
GO:0036297 |
interstrand cross-link repair(GO:0036297) |
| 0.3 |
0.3 |
GO:1901563 |
response to camptothecin(GO:1901563) |
| 0.3 |
4.1 |
GO:1904816 |
positive regulation of protein localization to chromosome, telomeric region(GO:1904816) |
| 0.3 |
0.3 |
GO:0035519 |
protein K29-linked ubiquitination(GO:0035519) |
| 0.3 |
2.0 |
GO:0090050 |
positive regulation of cell migration involved in sprouting angiogenesis(GO:0090050) |
| 0.3 |
2.7 |
GO:0006517 |
protein deglycosylation(GO:0006517) |
| 0.3 |
10.1 |
GO:0000462 |
maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000462) |
| 0.3 |
1.7 |
GO:0048537 |
mucosal-associated lymphoid tissue development(GO:0048537) Peyer's patch development(GO:0048541) |
| 0.3 |
1.0 |
GO:0036092 |
phosphatidylinositol-3-phosphate biosynthetic process(GO:0036092) |
| 0.3 |
1.0 |
GO:1901097 |
negative regulation of autophagosome maturation(GO:1901097) |
| 0.3 |
0.3 |
GO:0030202 |
heparin metabolic process(GO:0030202) |
| 0.3 |
1.3 |
GO:2000676 |
regulation of type B pancreatic cell apoptotic process(GO:2000674) positive regulation of type B pancreatic cell apoptotic process(GO:2000676) |
| 0.3 |
1.3 |
GO:0006297 |
nucleotide-excision repair, DNA gap filling(GO:0006297) |
| 0.3 |
0.3 |
GO:0006529 |
asparagine biosynthetic process(GO:0006529) |
| 0.3 |
0.3 |
GO:0060971 |
embryonic heart tube left/right pattern formation(GO:0060971) |
| 0.3 |
1.7 |
GO:2000392 |
regulation of lamellipodium morphogenesis(GO:2000392) positive regulation of lamellipodium morphogenesis(GO:2000394) |
| 0.3 |
5.3 |
GO:0035329 |
hippo signaling(GO:0035329) |
| 0.3 |
2.3 |
GO:2000643 |
positive regulation of early endosome to late endosome transport(GO:2000643) |
| 0.3 |
3.9 |
GO:0051156 |
glucose 6-phosphate metabolic process(GO:0051156) |
| 0.3 |
3.3 |
GO:0035510 |
DNA dealkylation(GO:0035510) |
| 0.3 |
2.0 |
GO:0007221 |
positive regulation of transcription of Notch receptor target(GO:0007221) |
| 0.3 |
2.0 |
GO:0000963 |
mitochondrial RNA processing(GO:0000963) |
| 0.3 |
0.3 |
GO:0035384 |
thioester biosynthetic process(GO:0035384) acyl-CoA biosynthetic process(GO:0071616) |
| 0.3 |
8.4 |
GO:0010965 |
regulation of mitotic sister chromatid separation(GO:0010965) |
| 0.3 |
1.6 |
GO:0006543 |
glutamine catabolic process(GO:0006543) |
| 0.3 |
3.9 |
GO:0090224 |
regulation of spindle organization(GO:0090224) |
| 0.3 |
1.9 |
GO:0035729 |
response to hepatocyte growth factor(GO:0035728) cellular response to hepatocyte growth factor stimulus(GO:0035729) |
| 0.3 |
0.6 |
GO:0072015 |
glomerular visceral epithelial cell development(GO:0072015) glomerular epithelial cell development(GO:0072310) |
| 0.3 |
1.0 |
GO:0070476 |
rRNA (guanine-N7)-methylation(GO:0070476) |
| 0.3 |
0.6 |
GO:0071594 |
T cell differentiation in thymus(GO:0033077) thymocyte aggregation(GO:0071594) |
| 0.3 |
1.6 |
GO:0060297 |
regulation of sarcomere organization(GO:0060297) |
| 0.3 |
1.6 |
GO:1902775 |
mitochondrial large ribosomal subunit assembly(GO:1902775) |
| 0.3 |
4.1 |
GO:0002385 |
organ or tissue specific immune response(GO:0002251) mucosal immune response(GO:0002385) |
| 0.3 |
0.9 |
GO:0051639 |
actin filament network formation(GO:0051639) |
| 0.3 |
4.4 |
GO:0033260 |
nuclear DNA replication(GO:0033260) |
| 0.3 |
0.3 |
GO:0090205 |
positive regulation of cholesterol biosynthetic process(GO:0045542) positive regulation of cholesterol metabolic process(GO:0090205) |
| 0.3 |
2.5 |
GO:0008063 |
Toll signaling pathway(GO:0008063) |
| 0.3 |
2.8 |
GO:0048535 |
lymph node development(GO:0048535) |
| 0.3 |
0.9 |
GO:0009130 |
pyrimidine nucleoside monophosphate biosynthetic process(GO:0009130) |
| 0.3 |
4.3 |
GO:0030513 |
positive regulation of BMP signaling pathway(GO:0030513) |
| 0.3 |
0.6 |
GO:0060059 |
embryonic retina morphogenesis in camera-type eye(GO:0060059) |
| 0.3 |
2.5 |
GO:0006978 |
DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:0006978) |
| 0.3 |
0.6 |
GO:0010944 |
negative regulation of transcription by competitive promoter binding(GO:0010944) |
| 0.3 |
3.4 |
GO:2000178 |
negative regulation of neural precursor cell proliferation(GO:2000178) |
| 0.3 |
0.3 |
GO:0009957 |
epidermal cell fate specification(GO:0009957) |
| 0.3 |
6.7 |
GO:0040015 |
negative regulation of multicellular organism growth(GO:0040015) |
| 0.3 |
0.6 |
GO:0045472 |
response to ether(GO:0045472) |
| 0.3 |
2.4 |
GO:0090166 |
Golgi disassembly(GO:0090166) |
| 0.3 |
1.2 |
GO:0010040 |
response to iron(II) ion(GO:0010040) |
| 0.3 |
4.8 |
GO:0048538 |
thymus development(GO:0048538) |
| 0.3 |
4.2 |
GO:0034508 |
centromere complex assembly(GO:0034508) |
| 0.3 |
0.3 |
GO:1901796 |
regulation of signal transduction by p53 class mediator(GO:1901796) |
| 0.3 |
1.5 |
GO:0021854 |
hypothalamus development(GO:0021854) |
| 0.3 |
2.1 |
GO:0006122 |
mitochondrial electron transport, ubiquinol to cytochrome c(GO:0006122) |
| 0.3 |
0.9 |
GO:0042822 |
vitamin B6 metabolic process(GO:0042816) pyridoxal phosphate metabolic process(GO:0042822) pyridoxal phosphate biosynthetic process(GO:0042823) |
| 0.3 |
1.5 |
GO:0006369 |
termination of RNA polymerase II transcription(GO:0006369) |
| 0.3 |
0.9 |
GO:0035360 |
positive regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035360) |
| 0.3 |
0.3 |
GO:0001826 |
inner cell mass cell differentiation(GO:0001826) |
| 0.3 |
2.1 |
GO:0019321 |
pentose metabolic process(GO:0019321) |
| 0.3 |
0.3 |
GO:2000298 |
regulation of Rho-dependent protein serine/threonine kinase activity(GO:2000298) |
| 0.3 |
1.2 |
GO:0018158 |
protein oxidation(GO:0018158) |
| 0.3 |
2.4 |
GO:1900262 |
regulation of DNA-directed DNA polymerase activity(GO:1900262) positive regulation of DNA-directed DNA polymerase activity(GO:1900264) |
| 0.3 |
2.1 |
GO:0035090 |
maintenance of apical/basal cell polarity(GO:0035090) |
| 0.3 |
1.2 |
GO:0032439 |
endosome localization(GO:0032439) |
| 0.3 |
10.0 |
GO:0010501 |
RNA secondary structure unwinding(GO:0010501) |
| 0.3 |
1.5 |
GO:0002318 |
myeloid progenitor cell differentiation(GO:0002318) |
| 0.3 |
1.2 |
GO:0030576 |
Cajal body organization(GO:0030576) |
| 0.3 |
5.0 |
GO:0006613 |
cotranslational protein targeting to membrane(GO:0006613) |
| 0.3 |
1.2 |
GO:0006741 |
NADP biosynthetic process(GO:0006741) |
| 0.3 |
1.7 |
GO:0060759 |
regulation of response to cytokine stimulus(GO:0060759) |
| 0.3 |
0.9 |
GO:0006361 |
transcription initiation from RNA polymerase I promoter(GO:0006361) |
| 0.3 |
1.7 |
GO:1903847 |
regulation of aorta morphogenesis(GO:1903847) positive regulation of aorta morphogenesis(GO:1903849) |
| 0.3 |
6.3 |
GO:0035458 |
cellular response to interferon-beta(GO:0035458) |
| 0.3 |
0.6 |
GO:1990403 |
embryonic brain development(GO:1990403) |
| 0.3 |
0.6 |
GO:0008594 |
photoreceptor cell morphogenesis(GO:0008594) |
| 0.3 |
2.0 |
GO:0031119 |
tRNA pseudouridine synthesis(GO:0031119) |
| 0.3 |
0.3 |
GO:0034968 |
histone lysine methylation(GO:0034968) |
| 0.3 |
0.9 |
GO:0035886 |
vascular smooth muscle cell differentiation(GO:0035886) |
| 0.3 |
3.4 |
GO:0001658 |
branching involved in ureteric bud morphogenesis(GO:0001658) |
| 0.3 |
3.9 |
GO:0003334 |
keratinocyte development(GO:0003334) |
| 0.3 |
2.0 |
GO:0061299 |
retina vasculature morphogenesis in camera-type eye(GO:0061299) |
| 0.3 |
1.1 |
GO:0061029 |
eyelid development in camera-type eye(GO:0061029) |
| 0.3 |
5.6 |
GO:0035873 |
lactate transport(GO:0015727) lactate transmembrane transport(GO:0035873) plasma membrane lactate transport(GO:0035879) |
| 0.3 |
2.5 |
GO:0033209 |
tumor necrosis factor-mediated signaling pathway(GO:0033209) |
| 0.3 |
0.6 |
GO:0015712 |
hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
| 0.3 |
2.8 |
GO:1903333 |
regulation of protein folding(GO:1903332) negative regulation of protein folding(GO:1903333) |
| 0.3 |
1.4 |
GO:0046598 |
positive regulation of viral entry into host cell(GO:0046598) |
| 0.3 |
5.8 |
GO:0000027 |
ribosomal large subunit assembly(GO:0000027) |
| 0.3 |
0.8 |
GO:0046060 |
dATP metabolic process(GO:0046060) |
| 0.3 |
0.6 |
GO:0000002 |
mitochondrial genome maintenance(GO:0000002) |
| 0.3 |
1.1 |
GO:0090037 |
positive regulation of protein kinase C signaling(GO:0090037) |
| 0.3 |
1.1 |
GO:0016266 |
O-glycan processing(GO:0016266) |
| 0.3 |
0.8 |
GO:0030327 |
prenylated protein catabolic process(GO:0030327) |
| 0.3 |
0.8 |
GO:0060766 |
negative regulation of androgen receptor signaling pathway(GO:0060766) |
| 0.3 |
0.8 |
GO:0036462 |
TRAIL-activated apoptotic signaling pathway(GO:0036462) |
| 0.3 |
0.8 |
GO:0002755 |
MyD88-dependent toll-like receptor signaling pathway(GO:0002755) |
| 0.3 |
3.0 |
GO:0072673 |
lamellipodium morphogenesis(GO:0072673) |
| 0.3 |
4.0 |
GO:0042407 |
cristae formation(GO:0042407) |
| 0.3 |
1.1 |
GO:0034975 |
protein folding in endoplasmic reticulum(GO:0034975) |
| 0.3 |
0.5 |
GO:0009086 |
methionine biosynthetic process(GO:0009086) |
| 0.3 |
0.3 |
GO:0043278 |
response to isoquinoline alkaloid(GO:0014072) response to morphine(GO:0043278) |
| 0.3 |
1.1 |
GO:0019509 |
L-methionine biosynthetic process from methylthioadenosine(GO:0019509) |
| 0.3 |
0.8 |
GO:0045204 |
MAPK export from nucleus(GO:0045204) |
| 0.3 |
1.3 |
GO:0051409 |
response to nitrosative stress(GO:0051409) |
| 0.3 |
1.9 |
GO:0031468 |
nuclear envelope reassembly(GO:0031468) |
| 0.3 |
0.3 |
GO:2000170 |
positive regulation of peptidyl-cysteine S-nitrosylation(GO:2000170) |
| 0.3 |
0.5 |
GO:0048333 |
mesodermal cell differentiation(GO:0048333) |
| 0.3 |
3.7 |
GO:0045292 |
mRNA cis splicing, via spliceosome(GO:0045292) |
| 0.3 |
1.8 |
GO:0034244 |
negative regulation of transcription elongation from RNA polymerase II promoter(GO:0034244) |
| 0.3 |
1.3 |
GO:2000210 |
positive regulation of anoikis(GO:2000210) |
| 0.3 |
0.3 |
GO:0035988 |
chondrocyte proliferation(GO:0035988) |
| 0.3 |
0.3 |
GO:0033313 |
meiotic cell cycle checkpoint(GO:0033313) |
| 0.3 |
0.8 |
GO:0055070 |
copper ion homeostasis(GO:0055070) |
| 0.3 |
0.3 |
GO:0048663 |
neuron fate commitment(GO:0048663) |
| 0.3 |
3.3 |
GO:0046827 |
positive regulation of protein export from nucleus(GO:0046827) |
| 0.3 |
1.5 |
GO:0045948 |
positive regulation of translational initiation(GO:0045948) |
| 0.3 |
1.0 |
GO:0045053 |
protein retention in Golgi apparatus(GO:0045053) |
| 0.3 |
0.3 |
GO:0031990 |
mRNA export from nucleus in response to heat stress(GO:0031990) |
| 0.3 |
0.3 |
GO:0001306 |
age-dependent response to oxidative stress(GO:0001306) age-dependent general metabolic decline(GO:0007571) |
| 0.3 |
2.8 |
GO:0033235 |
positive regulation of protein sumoylation(GO:0033235) |
| 0.3 |
1.8 |
GO:0033353 |
S-adenosylmethionine cycle(GO:0033353) |
| 0.3 |
2.0 |
GO:1903960 |
negative regulation of anion transmembrane transport(GO:1903960) |
| 0.3 |
1.3 |
GO:0007080 |
mitotic metaphase plate congression(GO:0007080) |
| 0.3 |
2.8 |
GO:0050684 |
regulation of mRNA processing(GO:0050684) |
| 0.3 |
0.5 |
GO:0018214 |
peptidyl-glutamic acid carboxylation(GO:0017187) protein carboxylation(GO:0018214) |
| 0.3 |
0.5 |
GO:0030277 |
maintenance of gastrointestinal epithelium(GO:0030277) |
| 0.3 |
2.0 |
GO:0071157 |
negative regulation of cell cycle arrest(GO:0071157) |
| 0.3 |
0.3 |
GO:0035898 |
parathyroid hormone secretion(GO:0035898) |
| 0.3 |
0.5 |
GO:0030865 |
cortical cytoskeleton organization(GO:0030865) |
| 0.3 |
0.3 |
GO:0001788 |
antibody-dependent cellular cytotoxicity(GO:0001788) |
| 0.2 |
1.7 |
GO:0045793 |
positive regulation of cell size(GO:0045793) |
| 0.2 |
1.5 |
GO:0038092 |
nodal signaling pathway(GO:0038092) |
| 0.2 |
0.5 |
GO:0000957 |
mitochondrial RNA catabolic process(GO:0000957) regulation of mitochondrial RNA catabolic process(GO:0000960) |
| 0.2 |
1.0 |
GO:0032511 |
late endosome to vacuole transport via multivesicular body sorting pathway(GO:0032511) protein targeting to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043328) |
| 0.2 |
2.5 |
GO:0032780 |
negative regulation of ATPase activity(GO:0032780) |
| 0.2 |
1.0 |
GO:1904668 |
positive regulation of ubiquitin protein ligase activity(GO:1904668) |
| 0.2 |
0.7 |
GO:0097623 |
potassium ion export across plasma membrane(GO:0097623) regulation of potassium ion export(GO:1902302) |
| 0.2 |
3.2 |
GO:0097062 |
dendritic spine maintenance(GO:0097062) |
| 0.2 |
1.7 |
GO:1904217 |
regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904217) positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904219) regulation of serine C-palmitoyltransferase activity(GO:1904220) positive regulation of serine C-palmitoyltransferase activity(GO:1904222) |
| 0.2 |
0.2 |
GO:0060339 |
negative regulation of type I interferon-mediated signaling pathway(GO:0060339) |
| 0.2 |
0.2 |
GO:0090035 |
regulation of chaperone-mediated protein complex assembly(GO:0090034) positive regulation of chaperone-mediated protein complex assembly(GO:0090035) |
| 0.2 |
0.2 |
GO:0090091 |
positive regulation of extracellular matrix disassembly(GO:0090091) |
| 0.2 |
0.2 |
GO:0045583 |
regulation of cytotoxic T cell differentiation(GO:0045583) positive regulation of cytotoxic T cell differentiation(GO:0045585) |
| 0.2 |
2.4 |
GO:0080009 |
mRNA methylation(GO:0080009) |
| 0.2 |
2.9 |
GO:0009954 |
proximal/distal pattern formation(GO:0009954) |
| 0.2 |
1.0 |
GO:0008616 |
queuosine biosynthetic process(GO:0008616) queuosine metabolic process(GO:0046116) |
| 0.2 |
0.5 |
GO:0034382 |
chylomicron remnant clearance(GO:0034382) triglyceride-rich lipoprotein particle clearance(GO:0071830) |
| 0.2 |
0.5 |
GO:2000680 |
regulation of rubidium ion transport(GO:2000680) |
| 0.2 |
0.7 |
GO:1902566 |
regulation of eosinophil activation(GO:1902566) |
| 0.2 |
0.5 |
GO:0002183 |
cytoplasmic translational initiation(GO:0002183) |
| 0.2 |
0.5 |
GO:0097411 |
hypoxia-inducible factor-1alpha signaling pathway(GO:0097411) |
| 0.2 |
7.0 |
GO:0006405 |
RNA export from nucleus(GO:0006405) |
| 0.2 |
0.5 |
GO:0006379 |
mRNA cleavage(GO:0006379) |
| 0.2 |
1.0 |
GO:1904008 |
cellular response to salt(GO:1902075) response to monosodium glutamate(GO:1904008) cellular response to monosodium glutamate(GO:1904009) |
| 0.2 |
2.2 |
GO:0002097 |
tRNA wobble base modification(GO:0002097) |
| 0.2 |
3.6 |
GO:0060351 |
cartilage development involved in endochondral bone morphogenesis(GO:0060351) |
| 0.2 |
0.5 |
GO:1904251 |
regulation of bile acid metabolic process(GO:1904251) |
| 0.2 |
0.2 |
GO:0021593 |
rhombomere morphogenesis(GO:0021593) |
| 0.2 |
2.1 |
GO:0031397 |
negative regulation of protein ubiquitination(GO:0031397) |
| 0.2 |
0.2 |
GO:0060390 |
regulation of SMAD protein import into nucleus(GO:0060390) |
| 0.2 |
6.4 |
GO:0021591 |
ventricular system development(GO:0021591) |
| 0.2 |
0.2 |
GO:0001732 |
formation of cytoplasmic translation initiation complex(GO:0001732) |
| 0.2 |
0.5 |
GO:0000491 |
small nucleolar ribonucleoprotein complex assembly(GO:0000491) box C/D snoRNP assembly(GO:0000492) |
| 0.2 |
1.2 |
GO:1902373 |
negative regulation of mRNA catabolic process(GO:1902373) |
| 0.2 |
0.2 |
GO:0030422 |
production of siRNA involved in RNA interference(GO:0030422) |
| 0.2 |
5.2 |
GO:0030488 |
tRNA methylation(GO:0030488) |
| 0.2 |
1.4 |
GO:0035437 |
maintenance of protein localization in endoplasmic reticulum(GO:0035437) |
| 0.2 |
0.5 |
GO:0051013 |
microtubule severing(GO:0051013) |
| 0.2 |
0.9 |
GO:0006730 |
one-carbon metabolic process(GO:0006730) |
| 0.2 |
1.2 |
GO:0035469 |
determination of pancreatic left/right asymmetry(GO:0035469) |
| 0.2 |
3.2 |
GO:0030150 |
protein import into mitochondrial matrix(GO:0030150) |
| 0.2 |
1.6 |
GO:0030224 |
monocyte differentiation(GO:0030224) |
| 0.2 |
1.2 |
GO:0071679 |
commissural neuron axon guidance(GO:0071679) |
| 0.2 |
0.5 |
GO:0032205 |
negative regulation of telomere maintenance(GO:0032205) |
| 0.2 |
0.7 |
GO:0009644 |
response to high light intensity(GO:0009644) |
| 0.2 |
0.9 |
GO:0019276 |
UDP-N-acetylgalactosamine metabolic process(GO:0019276) |
| 0.2 |
1.6 |
GO:0042590 |
antigen processing and presentation of exogenous peptide antigen via MHC class I(GO:0042590) |
| 0.2 |
0.2 |
GO:0006105 |
succinate metabolic process(GO:0006105) |
| 0.2 |
0.5 |
GO:0036072 |
intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
| 0.2 |
0.9 |
GO:0070886 |
positive regulation of calcineurin-NFAT signaling cascade(GO:0070886) |
| 0.2 |
2.2 |
GO:0006560 |
proline metabolic process(GO:0006560) |
| 0.2 |
1.8 |
GO:0006261 |
DNA-dependent DNA replication(GO:0006261) |
| 0.2 |
0.2 |
GO:0060457 |
negative regulation of digestive system process(GO:0060457) |
| 0.2 |
0.7 |
GO:0030208 |
dermatan sulfate biosynthetic process(GO:0030208) |
| 0.2 |
0.2 |
GO:0000305 |
response to oxygen radical(GO:0000305) |
| 0.2 |
0.4 |
GO:0042536 |
negative regulation of tumor necrosis factor biosynthetic process(GO:0042536) |
| 0.2 |
0.7 |
GO:0045647 |
negative regulation of erythrocyte differentiation(GO:0045647) |
| 0.2 |
0.9 |
GO:0046391 |
5-phosphoribose 1-diphosphate biosynthetic process(GO:0006015) 5-phosphoribose 1-diphosphate metabolic process(GO:0046391) |
| 0.2 |
0.7 |
GO:0072697 |
protein localization to cell cortex(GO:0072697) |
| 0.2 |
1.5 |
GO:0035871 |
protein K11-linked deubiquitination(GO:0035871) |
| 0.2 |
0.9 |
GO:0090209 |
negative regulation of triglyceride metabolic process(GO:0090209) |
| 0.2 |
0.2 |
GO:0002669 |
positive regulation of T cell anergy(GO:0002669) positive regulation of lymphocyte anergy(GO:0002913) |
| 0.2 |
0.4 |
GO:0048069 |
eye pigmentation(GO:0048069) |
| 0.2 |
5.4 |
GO:0030835 |
negative regulation of actin filament depolymerization(GO:0030835) |
| 0.2 |
0.2 |
GO:1901987 |
regulation of cell cycle phase transition(GO:1901987) |
| 0.2 |
1.1 |
GO:0048934 |
peripheral nervous system neuron differentiation(GO:0048934) peripheral nervous system neuron development(GO:0048935) |
| 0.2 |
0.4 |
GO:0006419 |
alanyl-tRNA aminoacylation(GO:0006419) |
| 0.2 |
3.5 |
GO:1902043 |
positive regulation of extrinsic apoptotic signaling pathway via death domain receptors(GO:1902043) |
| 0.2 |
0.9 |
GO:0043615 |
astrocyte cell migration(GO:0043615) |
| 0.2 |
2.2 |
GO:0030330 |
DNA damage response, signal transduction by p53 class mediator(GO:0030330) |
| 0.2 |
0.9 |
GO:0035845 |
photoreceptor cell outer segment organization(GO:0035845) |
| 0.2 |
1.9 |
GO:2001022 |
positive regulation of response to DNA damage stimulus(GO:2001022) |
| 0.2 |
0.6 |
GO:0006428 |
isoleucyl-tRNA aminoacylation(GO:0006428) |
| 0.2 |
4.3 |
GO:0003301 |
physiological muscle hypertrophy(GO:0003298) physiological cardiac muscle hypertrophy(GO:0003301) cell growth involved in cardiac muscle cell development(GO:0061049) |
| 0.2 |
0.2 |
GO:0001928 |
regulation of exocyst assembly(GO:0001928) |
| 0.2 |
0.6 |
GO:0060282 |
positive regulation of oocyte development(GO:0060282) |
| 0.2 |
0.4 |
GO:0071763 |
nuclear membrane organization(GO:0071763) |
| 0.2 |
0.4 |
GO:0000290 |
deadenylation-dependent decapping of nuclear-transcribed mRNA(GO:0000290) |
| 0.2 |
0.4 |
GO:1901889 |
negative regulation of cell junction assembly(GO:1901889) |
| 0.2 |
0.8 |
GO:1904587 |
glycoprotein ERAD pathway(GO:0097466) response to glycoprotein(GO:1904587) |
| 0.2 |
1.3 |
GO:0048747 |
muscle fiber development(GO:0048747) |
| 0.2 |
0.4 |
GO:0045837 |
negative regulation of mitochondrial membrane potential(GO:0010917) negative regulation of membrane potential(GO:0045837) |
| 0.2 |
0.6 |
GO:0048211 |
Golgi vesicle docking(GO:0048211) |
| 0.2 |
0.8 |
GO:0014722 |
regulation of skeletal muscle contraction by calcium ion signaling(GO:0014722) |
| 0.2 |
1.0 |
GO:0042095 |
interferon-gamma biosynthetic process(GO:0042095) |
| 0.2 |
2.1 |
GO:0010388 |
cullin deneddylation(GO:0010388) |
| 0.2 |
0.4 |
GO:0032066 |
nucleolus to nucleoplasm transport(GO:0032066) |
| 0.2 |
0.8 |
GO:0015819 |
lysine transport(GO:0015819) |
| 0.2 |
5.9 |
GO:2000249 |
regulation of actin cytoskeleton reorganization(GO:2000249) |
| 0.2 |
2.0 |
GO:0006353 |
DNA-templated transcription, termination(GO:0006353) |
| 0.2 |
2.2 |
GO:0042744 |
hydrogen peroxide catabolic process(GO:0042744) |
| 0.2 |
1.4 |
GO:0021800 |
cerebral cortex tangential migration(GO:0021800) |
| 0.2 |
2.8 |
GO:0070979 |
protein K11-linked ubiquitination(GO:0070979) |
| 0.2 |
0.6 |
GO:2000018 |
regulation of male gonad development(GO:2000018) |
| 0.2 |
1.0 |
GO:0030035 |
microspike assembly(GO:0030035) |
| 0.2 |
0.8 |
GO:1904715 |
negative regulation of chaperone-mediated autophagy(GO:1904715) |
| 0.2 |
0.4 |
GO:0046501 |
protoporphyrinogen IX metabolic process(GO:0046501) |
| 0.2 |
0.4 |
GO:0010667 |
negative regulation of cardiac muscle cell apoptotic process(GO:0010667) |
| 0.2 |
0.2 |
GO:0060155 |
platelet dense granule organization(GO:0060155) |
| 0.2 |
1.4 |
GO:0090031 |
positive regulation of steroid hormone biosynthetic process(GO:0090031) |
| 0.2 |
10.6 |
GO:0006413 |
translational initiation(GO:0006413) |
| 0.2 |
0.6 |
GO:0051151 |
negative regulation of smooth muscle cell differentiation(GO:0051151) |
| 0.2 |
12.0 |
GO:0008033 |
tRNA processing(GO:0008033) |
| 0.2 |
0.2 |
GO:0045059 |
positive thymic T cell selection(GO:0045059) |
| 0.2 |
2.9 |
GO:0048844 |
artery morphogenesis(GO:0048844) |
| 0.2 |
0.6 |
GO:0000087 |
mitotic M phase(GO:0000087) mitotic cell cycle phase(GO:0098763) |
| 0.2 |
1.5 |
GO:0010606 |
positive regulation of cytoplasmic mRNA processing body assembly(GO:0010606) |
| 0.2 |
2.3 |
GO:0032526 |
response to retinoic acid(GO:0032526) |
| 0.2 |
1.3 |
GO:0032790 |
ribosome disassembly(GO:0032790) |
| 0.2 |
0.2 |
GO:0090241 |
negative regulation of histone H4 acetylation(GO:0090241) |
| 0.2 |
0.6 |
GO:0031086 |
nuclear-transcribed mRNA catabolic process, deadenylation-independent decay(GO:0031086) deadenylation-independent decapping of nuclear-transcribed mRNA(GO:0031087) |
| 0.2 |
2.1 |
GO:0042149 |
cellular response to glucose starvation(GO:0042149) |
| 0.2 |
0.6 |
GO:0031128 |
developmental induction(GO:0031128) |
| 0.2 |
0.9 |
GO:0060040 |
retinal bipolar neuron differentiation(GO:0060040) |
| 0.2 |
8.4 |
GO:0006513 |
protein monoubiquitination(GO:0006513) |
| 0.2 |
1.3 |
GO:0003084 |
positive regulation of systemic arterial blood pressure(GO:0003084) |
| 0.2 |
0.7 |
GO:0070126 |
mitochondrial translational termination(GO:0070126) |
| 0.2 |
1.1 |
GO:0030388 |
fructose 1,6-bisphosphate metabolic process(GO:0030388) |
| 0.2 |
0.2 |
GO:0016573 |
histone acetylation(GO:0016573) |
| 0.2 |
0.7 |
GO:0018202 |
peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) peptidyl-histidine modification(GO:0018202) |
| 0.2 |
1.3 |
GO:0051014 |
actin filament severing(GO:0051014) |
| 0.2 |
0.9 |
GO:0070373 |
negative regulation of ERK1 and ERK2 cascade(GO:0070373) |
| 0.2 |
4.9 |
GO:0002181 |
cytoplasmic translation(GO:0002181) |
| 0.2 |
0.7 |
GO:0042276 |
error-prone translesion synthesis(GO:0042276) |
| 0.2 |
0.2 |
GO:0042482 |
positive regulation of odontogenesis(GO:0042482) |
| 0.2 |
0.7 |
GO:2000370 |
positive regulation of clathrin-mediated endocytosis(GO:2000370) |
| 0.2 |
0.9 |
GO:0046498 |
S-adenosylhomocysteine metabolic process(GO:0046498) |
| 0.2 |
0.9 |
GO:0018027 |
peptidyl-lysine dimethylation(GO:0018027) |
| 0.2 |
0.5 |
GO:0006657 |
CDP-choline pathway(GO:0006657) |
| 0.2 |
2.5 |
GO:0030497 |
fatty acid elongation(GO:0030497) |
| 0.2 |
0.4 |
GO:0070837 |
dehydroascorbic acid transport(GO:0070837) |
| 0.2 |
1.6 |
GO:0001731 |
formation of translation preinitiation complex(GO:0001731) |
| 0.2 |
0.5 |
GO:0022027 |
interkinetic nuclear migration(GO:0022027) |
| 0.2 |
1.2 |
GO:0030901 |
midbrain development(GO:0030901) |
| 0.2 |
0.9 |
GO:0006451 |
selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
| 0.2 |
0.7 |
GO:1903553 |
positive regulation of extracellular exosome assembly(GO:1903553) |
| 0.2 |
3.2 |
GO:0045599 |
negative regulation of fat cell differentiation(GO:0045599) |
| 0.2 |
0.2 |
GO:0070813 |
hydrogen sulfide metabolic process(GO:0070813) |
| 0.2 |
1.4 |
GO:0043374 |
CD8-positive, alpha-beta T cell differentiation(GO:0043374) |
| 0.2 |
0.5 |
GO:0030432 |
phasic smooth muscle contraction(GO:0014821) peristalsis(GO:0030432) |
| 0.2 |
2.2 |
GO:0044381 |
glucose import in response to insulin stimulus(GO:0044381) regulation of glucose import in response to insulin stimulus(GO:2001273) |
| 0.2 |
0.8 |
GO:0042758 |
long-chain fatty acid catabolic process(GO:0042758) |
| 0.2 |
2.5 |
GO:0000470 |
maturation of LSU-rRNA(GO:0000470) |
| 0.2 |
0.3 |
GO:0001778 |
plasma membrane repair(GO:0001778) |
| 0.2 |
0.8 |
GO:0040016 |
embryonic cleavage(GO:0040016) |
| 0.2 |
0.5 |
GO:1903232 |
melanosome assembly(GO:1903232) |
| 0.2 |
0.2 |
GO:0010833 |
telomere maintenance via telomere lengthening(GO:0010833) |
| 0.2 |
2.1 |
GO:0042273 |
ribosomal large subunit biogenesis(GO:0042273) |
| 0.2 |
0.2 |
GO:2000279 |
negative regulation of DNA biosynthetic process(GO:2000279) |
| 0.2 |
0.5 |
GO:0042275 |
error-free postreplication DNA repair(GO:0042275) |
| 0.2 |
0.6 |
GO:0036480 |
neuron intrinsic apoptotic signaling pathway in response to oxidative stress(GO:0036480) regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903376) |
| 0.2 |
0.3 |
GO:0022616 |
DNA strand elongation(GO:0022616) |
| 0.2 |
2.4 |
GO:0048026 |
positive regulation of mRNA splicing, via spliceosome(GO:0048026) |
| 0.2 |
0.8 |
GO:0031047 |
gene silencing by RNA(GO:0031047) |
| 0.2 |
1.0 |
GO:0050667 |
homocysteine metabolic process(GO:0050667) |
| 0.2 |
1.4 |
GO:1901741 |
positive regulation of myoblast fusion(GO:1901741) |
| 0.2 |
0.5 |
GO:0036342 |
post-anal tail morphogenesis(GO:0036342) |
| 0.2 |
0.5 |
GO:0046487 |
glyoxylate metabolic process(GO:0046487) |
| 0.2 |
2.2 |
GO:0070534 |
protein K63-linked ubiquitination(GO:0070534) |
| 0.2 |
2.8 |
GO:0048025 |
negative regulation of mRNA splicing, via spliceosome(GO:0048025) |
| 0.2 |
0.5 |
GO:0070301 |
cellular response to hydrogen peroxide(GO:0070301) |
| 0.2 |
2.7 |
GO:0043631 |
RNA polyadenylation(GO:0043631) |
| 0.2 |
0.8 |
GO:0042769 |
DNA damage response, detection of DNA damage(GO:0042769) |
| 0.2 |
0.9 |
GO:0030520 |
intracellular estrogen receptor signaling pathway(GO:0030520) |
| 0.2 |
0.8 |
GO:0009950 |
dorsal/ventral axis specification(GO:0009950) |
| 0.2 |
0.6 |
GO:0018206 |
peptidyl-methionine modification(GO:0018206) |
| 0.2 |
0.8 |
GO:0035025 |
positive regulation of Rho protein signal transduction(GO:0035025) |
| 0.2 |
0.2 |
GO:0050918 |
positive chemotaxis(GO:0050918) |
| 0.2 |
0.5 |
GO:0043984 |
histone H4-K16 acetylation(GO:0043984) |
| 0.2 |
0.2 |
GO:0071374 |
cellular response to parathyroid hormone stimulus(GO:0071374) |
| 0.2 |
0.6 |
GO:0016479 |
negative regulation of transcription from RNA polymerase I promoter(GO:0016479) |
| 0.2 |
0.8 |
GO:0071294 |
cellular response to zinc ion(GO:0071294) |
| 0.1 |
1.2 |
GO:0043403 |
skeletal muscle tissue regeneration(GO:0043403) |
| 0.1 |
0.9 |
GO:0040001 |
establishment of mitotic spindle localization(GO:0040001) |
| 0.1 |
0.4 |
GO:1903912 |
negative regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation(GO:1903912) |
| 0.1 |
20.8 |
GO:0000398 |
RNA splicing, via transesterification reactions with bulged adenosine as nucleophile(GO:0000377) mRNA splicing, via spliceosome(GO:0000398) |
| 0.1 |
0.4 |
GO:2000047 |
regulation of cell-cell adhesion mediated by cadherin(GO:2000047) |
| 0.1 |
1.2 |
GO:0071225 |
cellular response to muramyl dipeptide(GO:0071225) |
| 0.1 |
1.3 |
GO:0051561 |
positive regulation of mitochondrial calcium ion concentration(GO:0051561) |
| 0.1 |
0.7 |
GO:0033210 |
leptin-mediated signaling pathway(GO:0033210) |
| 0.1 |
0.6 |
GO:0035372 |
protein localization to microtubule(GO:0035372) |
| 0.1 |
0.7 |
GO:0045019 |
negative regulation of nitric oxide biosynthetic process(GO:0045019) negative regulation of nitric oxide metabolic process(GO:1904406) |
| 0.1 |
0.4 |
GO:0097089 |
methyl-branched fatty acid metabolic process(GO:0097089) |
| 0.1 |
0.6 |
GO:2001270 |
regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001270) |
| 0.1 |
0.4 |
GO:0006556 |
S-adenosylmethionine biosynthetic process(GO:0006556) |
| 0.1 |
0.1 |
GO:0045618 |
positive regulation of keratinocyte differentiation(GO:0045618) |
| 0.1 |
0.4 |
GO:0045743 |
positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
| 0.1 |
0.9 |
GO:0034773 |
histone H4-K20 trimethylation(GO:0034773) |
| 0.1 |
1.1 |
GO:0030490 |
maturation of SSU-rRNA(GO:0030490) |
| 0.1 |
4.7 |
GO:0009060 |
aerobic respiration(GO:0009060) |
| 0.1 |
0.4 |
GO:1902047 |
polyamine transmembrane transport(GO:1902047) regulation of polyamine transmembrane transport(GO:1902267) negative regulation of polyamine transmembrane transport(GO:1902268) |
| 0.1 |
0.3 |
GO:1902065 |
response to L-glutamate(GO:1902065) |
| 0.1 |
1.3 |
GO:0001947 |
heart looping(GO:0001947) |
| 0.1 |
3.1 |
GO:0000186 |
activation of MAPKK activity(GO:0000186) |
| 0.1 |
1.4 |
GO:0019730 |
antimicrobial humoral response(GO:0019730) |
| 0.1 |
4.0 |
GO:0042168 |
heme metabolic process(GO:0042168) |
| 0.1 |
2.7 |
GO:0051298 |
centrosome duplication(GO:0051298) |
| 0.1 |
1.0 |
GO:0031339 |
negative regulation of vesicle fusion(GO:0031339) |
| 0.1 |
1.1 |
GO:0046622 |
positive regulation of organ growth(GO:0046622) |
| 0.1 |
0.1 |
GO:0045766 |
positive regulation of angiogenesis(GO:0045766) |
| 0.1 |
0.4 |
GO:0035521 |
monoubiquitinated histone deubiquitination(GO:0035521) monoubiquitinated histone H2A deubiquitination(GO:0035522) |
| 0.1 |
1.5 |
GO:0016925 |
protein sumoylation(GO:0016925) |
| 0.1 |
0.4 |
GO:0097284 |
hepatocyte apoptotic process(GO:0097284) |
| 0.1 |
0.3 |
GO:0002035 |
brain renin-angiotensin system(GO:0002035) |
| 0.1 |
0.1 |
GO:0033292 |
T-tubule organization(GO:0033292) |
| 0.1 |
0.3 |
GO:0006167 |
AMP biosynthetic process(GO:0006167) |
| 0.1 |
0.3 |
GO:0072610 |
interleukin-12 secretion(GO:0072610) regulation of interleukin-12 secretion(GO:2001182) positive regulation of interleukin-12 secretion(GO:2001184) |
| 0.1 |
0.5 |
GO:0070207 |
protein homotrimerization(GO:0070207) |
| 0.1 |
0.5 |
GO:0060216 |
definitive hemopoiesis(GO:0060216) |
| 0.1 |
0.4 |
GO:0034115 |
negative regulation of heterotypic cell-cell adhesion(GO:0034115) cell-cell adhesion involved in gastrulation(GO:0070586) regulation of cell-cell adhesion involved in gastrulation(GO:0070587) |
| 0.1 |
0.4 |
GO:2000852 |
regulation of corticosterone secretion(GO:2000852) |
| 0.1 |
0.3 |
GO:0036289 |
peptidyl-serine autophosphorylation(GO:0036289) |
| 0.1 |
1.3 |
GO:0080182 |
histone H3-K4 trimethylation(GO:0080182) |
| 0.1 |
0.1 |
GO:0061371 |
determination of heart left/right asymmetry(GO:0061371) |
| 0.1 |
0.5 |
GO:0072584 |
caveolin-mediated endocytosis(GO:0072584) |
| 0.1 |
0.3 |
GO:2000324 |
positive regulation of glucocorticoid receptor signaling pathway(GO:2000324) |
| 0.1 |
0.8 |
GO:0006004 |
fucose metabolic process(GO:0006004) |
| 0.1 |
2.0 |
GO:0032204 |
regulation of telomere maintenance(GO:0032204) |
| 0.1 |
5.2 |
GO:0043484 |
regulation of RNA splicing(GO:0043484) |
| 0.1 |
0.1 |
GO:0006706 |
steroid catabolic process(GO:0006706) |
| 0.1 |
0.1 |
GO:0060166 |
olfactory pit development(GO:0060166) |
| 0.1 |
0.6 |
GO:0006564 |
L-serine biosynthetic process(GO:0006564) |
| 0.1 |
0.5 |
GO:0006265 |
DNA topological change(GO:0006265) |
| 0.1 |
3.0 |
GO:2000134 |
negative regulation of G1/S transition of mitotic cell cycle(GO:2000134) |
| 0.1 |
0.7 |
GO:0003085 |
negative regulation of systemic arterial blood pressure(GO:0003085) |
| 0.1 |
3.1 |
GO:0032481 |
positive regulation of type I interferon production(GO:0032481) |
| 0.1 |
1.0 |
GO:1900027 |
regulation of ruffle assembly(GO:1900027) |
| 0.1 |
6.1 |
GO:0006334 |
nucleosome assembly(GO:0006334) |
| 0.1 |
1.9 |
GO:0007492 |
endoderm development(GO:0007492) |
| 0.1 |
0.5 |
GO:0006020 |
inositol metabolic process(GO:0006020) |
| 0.1 |
1.0 |
GO:0006573 |
valine metabolic process(GO:0006573) |
| 0.1 |
0.5 |
GO:1903432 |
TORC1 signaling(GO:0038202) regulation of TORC1 signaling(GO:1903432) |
| 0.1 |
0.8 |
GO:0043982 |
histone H4-K5 acetylation(GO:0043981) histone H4-K8 acetylation(GO:0043982) |
| 0.1 |
1.5 |
GO:0050892 |
intestinal absorption(GO:0050892) |
| 0.1 |
2.0 |
GO:0032611 |
interleukin-1 beta production(GO:0032611) |
| 0.1 |
0.7 |
GO:0051461 |
regulation of corticotropin secretion(GO:0051459) positive regulation of corticotropin secretion(GO:0051461) |
| 0.1 |
0.8 |
GO:0045945 |
positive regulation of transcription from RNA polymerase III promoter(GO:0045945) |
| 0.1 |
0.6 |
GO:0035493 |
SNARE complex assembly(GO:0035493) |
| 0.1 |
0.3 |
GO:0019441 |
tryptophan catabolic process(GO:0006569) tryptophan catabolic process to kynurenine(GO:0019441) indole-containing compound catabolic process(GO:0042436) indolalkylamine catabolic process(GO:0046218) kynurenine metabolic process(GO:0070189) |
| 0.1 |
1.0 |
GO:0071447 |
cellular response to hydroperoxide(GO:0071447) |
| 0.1 |
0.6 |
GO:0010574 |
regulation of vascular endothelial growth factor production(GO:0010574) |
| 0.1 |
0.2 |
GO:2000192 |
negative regulation of fatty acid transport(GO:2000192) |
| 0.1 |
0.3 |
GO:0046032 |
ADP catabolic process(GO:0046032) |
| 0.1 |
1.1 |
GO:0050765 |
negative regulation of phagocytosis(GO:0050765) |
| 0.1 |
0.3 |
GO:0002467 |
germinal center formation(GO:0002467) |
| 0.1 |
1.1 |
GO:0006490 |
oligosaccharide-lipid intermediate biosynthetic process(GO:0006490) |
| 0.1 |
0.9 |
GO:0071356 |
cellular response to tumor necrosis factor(GO:0071356) |
| 0.1 |
1.4 |
GO:0044380 |
protein localization to cytoskeleton(GO:0044380) |
| 0.1 |
4.2 |
GO:0043966 |
histone H3 acetylation(GO:0043966) |
| 0.1 |
0.5 |
GO:0008053 |
mitochondrial fusion(GO:0008053) |
| 0.1 |
1.3 |
GO:0006221 |
pyrimidine nucleotide biosynthetic process(GO:0006221) |
| 0.1 |
2.6 |
GO:0007368 |
determination of left/right symmetry(GO:0007368) |
| 0.1 |
0.2 |
GO:0002903 |
negative regulation of B cell apoptotic process(GO:0002903) |
| 0.1 |
0.3 |
GO:1901072 |
glucosamine-containing compound catabolic process(GO:1901072) |
| 0.1 |
1.1 |
GO:0030213 |
hyaluronan biosynthetic process(GO:0030213) |
| 0.1 |
2.2 |
GO:0008156 |
negative regulation of DNA replication(GO:0008156) |
| 0.1 |
0.4 |
GO:0007603 |
phototransduction, visible light(GO:0007603) |
| 0.1 |
0.2 |
GO:0090383 |
phagosome acidification(GO:0090383) |
| 0.1 |
0.4 |
GO:0032902 |
nerve growth factor production(GO:0032902) |
| 0.1 |
1.2 |
GO:0034312 |
diol biosynthetic process(GO:0034312) sphingosine biosynthetic process(GO:0046512) sphingoid biosynthetic process(GO:0046520) |
| 0.1 |
5.0 |
GO:0044264 |
cellular polysaccharide metabolic process(GO:0044264) |
| 0.1 |
0.2 |
GO:0046716 |
muscle cell cellular homeostasis(GO:0046716) |
| 0.1 |
0.9 |
GO:0070816 |
phosphorylation of RNA polymerase II C-terminal domain(GO:0070816) |
| 0.1 |
0.8 |
GO:0032967 |
positive regulation of collagen biosynthetic process(GO:0032967) |
| 0.1 |
0.4 |
GO:0019254 |
carnitine metabolic process, CoA-linked(GO:0019254) |
| 0.1 |
0.6 |
GO:1900037 |
regulation of cellular response to hypoxia(GO:1900037) |
| 0.1 |
2.9 |
GO:0051225 |
spindle assembly(GO:0051225) |
| 0.1 |
0.5 |
GO:0048280 |
vesicle fusion with Golgi apparatus(GO:0048280) |
| 0.1 |
0.1 |
GO:1902837 |
amino acid neurotransmitter reuptake(GO:0051933) glutamate reuptake(GO:0051935) amino acid import into cell(GO:1902837) L-glutamate(1-) import into cell(GO:1903802) L-glutamate import into cell(GO:1990123) |
| 0.1 |
1.0 |
GO:0016339 |
calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
| 0.1 |
1.9 |
GO:0008631 |
intrinsic apoptotic signaling pathway in response to oxidative stress(GO:0008631) |
| 0.1 |
1.7 |
GO:0032781 |
positive regulation of ATPase activity(GO:0032781) |
| 0.1 |
0.2 |
GO:2000059 |
negative regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:2000059) |
| 0.1 |
2.0 |
GO:0010633 |
negative regulation of epithelial cell migration(GO:0010633) |
| 0.1 |
0.2 |
GO:0021562 |
vestibulocochlear nerve development(GO:0021562) |
| 0.1 |
0.6 |
GO:0030913 |
paranodal junction assembly(GO:0030913) |
| 0.1 |
0.2 |
GO:0014873 |
response to muscle activity involved in regulation of muscle adaptation(GO:0014873) |
| 0.1 |
0.2 |
GO:0030579 |
ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
| 0.1 |
2.5 |
GO:0015985 |
energy coupled proton transport, down electrochemical gradient(GO:0015985) ATP synthesis coupled proton transport(GO:0015986) |
| 0.1 |
0.6 |
GO:0090435 |
protein localization to nuclear envelope(GO:0090435) |
| 0.1 |
0.3 |
GO:0021698 |
cerebellar cortex structural organization(GO:0021698) |
| 0.1 |
0.6 |
GO:0007252 |
I-kappaB phosphorylation(GO:0007252) |
| 0.1 |
0.2 |
GO:0070670 |
response to interleukin-4(GO:0070670) |
| 0.1 |
0.1 |
GO:0060821 |
inactivation of X chromosome by DNA methylation(GO:0060821) |
| 0.1 |
0.2 |
GO:0070933 |
histone H4 deacetylation(GO:0070933) |
| 0.1 |
0.1 |
GO:0048308 |
organelle inheritance(GO:0048308) Golgi inheritance(GO:0048313) |
| 0.1 |
0.2 |
GO:0010259 |
multicellular organism aging(GO:0010259) |
| 0.1 |
0.3 |
GO:0060033 |
anatomical structure regression(GO:0060033) |
| 0.1 |
0.3 |
GO:0005976 |
polysaccharide metabolic process(GO:0005976) |
| 0.1 |
0.3 |
GO:0070537 |
histone H2A K63-linked deubiquitination(GO:0070537) |
| 0.1 |
0.8 |
GO:0032957 |
inositol trisphosphate metabolic process(GO:0032957) |
| 0.1 |
0.8 |
GO:0035036 |
binding of sperm to zona pellucida(GO:0007339) sperm-egg recognition(GO:0035036) |
| 0.1 |
0.3 |
GO:0071281 |
cellular response to iron ion(GO:0071281) iron ion import(GO:0097286) |
| 0.1 |
0.2 |
GO:0009880 |
embryonic pattern specification(GO:0009880) |
| 0.1 |
0.1 |
GO:0018026 |
peptidyl-lysine monomethylation(GO:0018026) |
| 0.1 |
0.2 |
GO:1901532 |
regulation of hematopoietic progenitor cell differentiation(GO:1901532) |
| 0.1 |
0.3 |
GO:0098734 |
protein depalmitoylation(GO:0002084) macromolecule depalmitoylation(GO:0098734) |
| 0.1 |
1.8 |
GO:0034605 |
cellular response to heat(GO:0034605) |
| 0.1 |
0.2 |
GO:0010890 |
positive regulation of sequestering of triglyceride(GO:0010890) |
| 0.1 |
0.3 |
GO:0050982 |
detection of mechanical stimulus(GO:0050982) |
| 0.1 |
0.9 |
GO:0051457 |
maintenance of protein location in nucleus(GO:0051457) |
| 0.1 |
0.2 |
GO:1990000 |
amyloid fibril formation(GO:1990000) |
| 0.1 |
0.8 |
GO:0070988 |
demethylation(GO:0070988) |
| 0.1 |
0.6 |
GO:0009992 |
cellular water homeostasis(GO:0009992) |
| 0.1 |
0.4 |
GO:0006968 |
cellular defense response(GO:0006968) |
| 0.1 |
0.4 |
GO:0051353 |
positive regulation of oxidoreductase activity(GO:0051353) |
| 0.1 |
0.6 |
GO:0036506 |
maintenance of unfolded protein(GO:0036506) maintenance of unfolded protein involved in ERAD pathway(GO:1904378) |
| 0.1 |
0.8 |
GO:0048873 |
homeostasis of number of cells within a tissue(GO:0048873) |
| 0.1 |
0.4 |
GO:0006123 |
mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
| 0.1 |
0.5 |
GO:0032534 |
regulation of microvillus assembly(GO:0032534) |
| 0.1 |
0.2 |
GO:0048630 |
skeletal muscle tissue growth(GO:0048630) |
| 0.1 |
0.2 |
GO:0052428 |
modulation of molecular function in other organism(GO:0044359) negative regulation of molecular function in other organism(GO:0044362) negative regulation of molecular function in other organism involved in symbiotic interaction(GO:0052204) modulation of molecular function in other organism involved in symbiotic interaction(GO:0052205) negative regulation by host of symbiont molecular function(GO:0052405) modification by host of symbiont molecular function(GO:0052428) |
| 0.1 |
0.3 |
GO:0045607 |
regulation of auditory receptor cell differentiation(GO:0045607) regulation of mechanoreceptor differentiation(GO:0045631) regulation of inner ear receptor cell differentiation(GO:2000980) |
| 0.1 |
0.2 |
GO:0090181 |
regulation of cholesterol metabolic process(GO:0090181) |
| 0.1 |
0.2 |
GO:0050779 |
RNA destabilization(GO:0050779) |
| 0.1 |
0.5 |
GO:0002011 |
morphogenesis of an epithelial sheet(GO:0002011) |
| 0.1 |
0.4 |
GO:0051657 |
maintenance of organelle location(GO:0051657) |
| 0.1 |
0.1 |
GO:0030578 |
PML body organization(GO:0030578) |
| 0.1 |
0.2 |
GO:0031532 |
actin cytoskeleton reorganization(GO:0031532) |
| 0.1 |
0.7 |
GO:0051567 |
histone H3-K9 methylation(GO:0051567) |
| 0.1 |
1.1 |
GO:0006744 |
ubiquinone biosynthetic process(GO:0006744) |
| 0.1 |
6.7 |
GO:0006417 |
regulation of translation(GO:0006417) |
| 0.1 |
0.2 |
GO:0045742 |
positive regulation of epidermal growth factor receptor signaling pathway(GO:0045742) positive regulation of ERBB signaling pathway(GO:1901186) |
| 0.1 |
0.3 |
GO:0014842 |
skeletal muscle satellite cell proliferation(GO:0014841) regulation of skeletal muscle satellite cell proliferation(GO:0014842) skeletal muscle cell proliferation(GO:0014856) regulation of skeletal muscle cell proliferation(GO:0014857) |
| 0.1 |
0.6 |
GO:0016574 |
histone ubiquitination(GO:0016574) |
| 0.1 |
0.3 |
GO:0046326 |
positive regulation of glucose import(GO:0046326) |
| 0.1 |
0.1 |
GO:0046121 |
deoxyribonucleoside catabolic process(GO:0046121) |
| 0.1 |
0.7 |
GO:0048706 |
embryonic skeletal system development(GO:0048706) |
| 0.1 |
0.7 |
GO:0060009 |
Sertoli cell development(GO:0060009) |
| 0.1 |
0.1 |
GO:0033683 |
nucleotide-excision repair, DNA incision(GO:0033683) |
| 0.1 |
0.8 |
GO:0044243 |
multicellular organism catabolic process(GO:0044243) |
| 0.1 |
0.2 |
GO:0006421 |
asparaginyl-tRNA aminoacylation(GO:0006421) |
| 0.1 |
0.4 |
GO:0048199 |
vesicle targeting, to, from or within Golgi(GO:0048199) |
| 0.1 |
0.3 |
GO:0010603 |
regulation of cytoplasmic mRNA processing body assembly(GO:0010603) |
| 0.1 |
1.3 |
GO:0032527 |
protein exit from endoplasmic reticulum(GO:0032527) |
| 0.1 |
0.1 |
GO:0016584 |
nucleosome positioning(GO:0016584) |
| 0.1 |
0.3 |
GO:0001522 |
pseudouridine synthesis(GO:0001522) |
| 0.1 |
0.4 |
GO:0000184 |
nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:0000184) |
| 0.1 |
0.4 |
GO:0007175 |
negative regulation of epidermal growth factor-activated receptor activity(GO:0007175) |
| 0.1 |
0.2 |
GO:0030502 |
negative regulation of bone mineralization(GO:0030502) |
| 0.1 |
0.2 |
GO:0002337 |
B-1a B cell differentiation(GO:0002337) |
| 0.1 |
0.2 |
GO:0006591 |
ornithine metabolic process(GO:0006591) |
| 0.1 |
1.0 |
GO:0043297 |
apical junction assembly(GO:0043297) |
| 0.1 |
0.2 |
GO:0045039 |
protein import into mitochondrial inner membrane(GO:0045039) |
| 0.1 |
0.1 |
GO:0006703 |
estrogen biosynthetic process(GO:0006703) |
| 0.1 |
0.2 |
GO:0070125 |
mitochondrial translational elongation(GO:0070125) |
| 0.1 |
0.2 |
GO:0060177 |
regulation of angiotensin metabolic process(GO:0060177) |
| 0.1 |
0.1 |
GO:0070966 |
nuclear-transcribed mRNA catabolic process, no-go decay(GO:0070966) |
| 0.1 |
0.3 |
GO:0016081 |
synaptic vesicle docking(GO:0016081) |
| 0.1 |
0.6 |
GO:0006471 |
protein ADP-ribosylation(GO:0006471) |
| 0.1 |
0.1 |
GO:0070102 |
interleukin-6-mediated signaling pathway(GO:0070102) |
| 0.1 |
0.4 |
GO:0061154 |
venous blood vessel morphogenesis(GO:0048845) endothelial tube morphogenesis(GO:0061154) |
| 0.1 |
0.3 |
GO:0048733 |
sebaceous gland development(GO:0048733) |
| 0.1 |
0.2 |
GO:0042274 |
ribosomal small subunit biogenesis(GO:0042274) |
| 0.1 |
0.5 |
GO:0044275 |
cellular carbohydrate catabolic process(GO:0044275) |
| 0.1 |
0.3 |
GO:0045218 |
zonula adherens maintenance(GO:0045218) |
| 0.1 |
0.1 |
GO:0045075 |
interleukin-12 biosynthetic process(GO:0042090) regulation of interleukin-12 biosynthetic process(GO:0045075) |
| 0.1 |
0.2 |
GO:2000483 |
negative regulation of interleukin-8 secretion(GO:2000483) |
| 0.1 |
0.1 |
GO:0090073 |
positive regulation of protein homodimerization activity(GO:0090073) |
| 0.1 |
0.7 |
GO:0046855 |
phosphorylated carbohydrate dephosphorylation(GO:0046838) inositol phosphate dephosphorylation(GO:0046855) |
| 0.1 |
0.3 |
GO:0019243 |
methylglyoxal metabolic process(GO:0009438) methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione(GO:0019243) methylglyoxal catabolic process(GO:0051596) methylglyoxal catabolic process to lactate(GO:0061727) |
| 0.1 |
0.8 |
GO:0001841 |
neural tube formation(GO:0001841) |
| 0.1 |
0.3 |
GO:0036233 |
glycine import(GO:0036233) |
| 0.1 |
0.2 |
GO:0070571 |
negative regulation of neuron projection regeneration(GO:0070571) |
| 0.1 |
0.4 |
GO:1902042 |
negative regulation of extrinsic apoptotic signaling pathway via death domain receptors(GO:1902042) |
| 0.1 |
0.1 |
GO:0061300 |
cerebellum vasculature development(GO:0061300) |
| 0.1 |
0.3 |
GO:0097503 |
sialylation(GO:0097503) |
| 0.0 |
0.6 |
GO:0006474 |
N-terminal protein amino acid acetylation(GO:0006474) |
| 0.0 |
0.2 |
GO:0090286 |
cytoskeletal anchoring at nuclear membrane(GO:0090286) |
| 0.0 |
0.2 |
GO:0002115 |
store-operated calcium entry(GO:0002115) |
| 0.0 |
0.3 |
GO:0070208 |
protein heterotrimerization(GO:0070208) |
| 0.0 |
0.3 |
GO:2000269 |
regulation of fibroblast apoptotic process(GO:2000269) |
| 0.0 |
0.2 |
GO:0070475 |
rRNA base methylation(GO:0070475) |
| 0.0 |
0.1 |
GO:0060916 |
mesenchymal cell proliferation involved in lung development(GO:0060916) |
| 0.0 |
0.1 |
GO:0006356 |
regulation of transcription from RNA polymerase I promoter(GO:0006356) |
| 0.0 |
0.5 |
GO:0008272 |
sulfate transport(GO:0008272) |
| 0.0 |
0.4 |
GO:0042102 |
positive regulation of T cell proliferation(GO:0042102) |
| 0.0 |
0.1 |
GO:0048742 |
regulation of skeletal muscle fiber development(GO:0048742) |
| 0.0 |
0.1 |
GO:1900026 |
positive regulation of substrate adhesion-dependent cell spreading(GO:1900026) |
| 0.0 |
0.2 |
GO:0006627 |
protein processing involved in protein targeting to mitochondrion(GO:0006627) |
| 0.0 |
1.4 |
GO:0045454 |
cell redox homeostasis(GO:0045454) |
| 0.0 |
0.1 |
GO:0010985 |
negative regulation of lipoprotein particle clearance(GO:0010985) |
| 0.0 |
0.1 |
GO:0070127 |
tRNA aminoacylation for mitochondrial protein translation(GO:0070127) |
| 0.0 |
0.0 |
GO:0098543 |
detection of bacterium(GO:0016045) detection of other organism(GO:0098543) |
| 0.0 |
6.8 |
GO:0006412 |
translation(GO:0006412) |
| 0.0 |
0.2 |
GO:0033561 |
regulation of water loss via skin(GO:0033561) establishment of skin barrier(GO:0061436) |
| 0.0 |
0.2 |
GO:1900119 |
positive regulation of execution phase of apoptosis(GO:1900119) |
| 0.0 |
0.5 |
GO:0060324 |
face development(GO:0060324) |
| 0.0 |
0.7 |
GO:0033539 |
fatty acid beta-oxidation using acyl-CoA dehydrogenase(GO:0033539) |
| 0.0 |
0.1 |
GO:0070327 |
thyroid hormone transport(GO:0070327) |
| 0.0 |
0.2 |
GO:0003170 |
heart valve development(GO:0003170) |
| 0.0 |
0.1 |
GO:0072321 |
chaperone-mediated protein transport(GO:0072321) |
| 0.0 |
0.3 |
GO:2000009 |
negative regulation of protein localization to cell surface(GO:2000009) |
| 0.0 |
0.1 |
GO:1903966 |
monounsaturated fatty acid metabolic process(GO:1903964) monounsaturated fatty acid biosynthetic process(GO:1903966) |
| 0.0 |
0.3 |
GO:0042035 |
regulation of cytokine biosynthetic process(GO:0042035) |
| 0.0 |
0.2 |
GO:0010595 |
positive regulation of endothelial cell migration(GO:0010595) |
| 0.0 |
0.1 |
GO:0035735 |
intraciliary transport involved in cilium morphogenesis(GO:0035735) |
| 0.0 |
0.1 |
GO:0006553 |
lysine metabolic process(GO:0006553) |
| 0.0 |
0.5 |
GO:0006986 |
response to unfolded protein(GO:0006986) |
| 0.0 |
0.0 |
GO:0006678 |
glucosylceramide metabolic process(GO:0006678) |
| 0.0 |
0.4 |
GO:0042770 |
signal transduction in response to DNA damage(GO:0042770) |
| 0.0 |
0.1 |
GO:0035106 |
operant conditioning(GO:0035106) |
| 0.0 |
0.1 |
GO:0071494 |
cellular response to UV-C(GO:0071494) |
| 0.0 |
0.1 |
GO:0048007 |
antigen processing and presentation of lipid antigen via MHC class Ib(GO:0048003) antigen processing and presentation, exogenous lipid antigen via MHC class Ib(GO:0048007) |
| 0.0 |
0.3 |
GO:0000154 |
rRNA modification(GO:0000154) |
| 0.0 |
0.1 |
GO:0046381 |
CMP-N-acetylneuraminate metabolic process(GO:0046381) |
| 0.0 |
0.1 |
GO:0035067 |
negative regulation of histone acetylation(GO:0035067) |
| 0.0 |
0.1 |
GO:0045852 |
pH elevation(GO:0045852) intracellular pH elevation(GO:0051454) |
| 0.0 |
0.1 |
GO:0042255 |
ribosome assembly(GO:0042255) |
| 0.0 |
0.1 |
GO:0042100 |
B cell proliferation(GO:0042100) |
| 0.0 |
0.2 |
GO:0033173 |
calcineurin-NFAT signaling cascade(GO:0033173) inositol phosphate-mediated signaling(GO:0048016) |
| 0.0 |
0.2 |
GO:0032755 |
positive regulation of interleukin-6 production(GO:0032755) |
| 0.0 |
0.3 |
GO:0042773 |
ATP synthesis coupled electron transport(GO:0042773) |
| 0.0 |
1.5 |
GO:0007030 |
Golgi organization(GO:0007030) |
| 0.0 |
0.1 |
GO:0072176 |
nephric duct development(GO:0072176) nephric duct morphogenesis(GO:0072178) |
| 0.0 |
0.1 |
GO:0007320 |
insemination(GO:0007320) |
| 0.0 |
0.2 |
GO:0019363 |
pyridine nucleotide biosynthetic process(GO:0019363) |
| 0.0 |
0.1 |
GO:0045604 |
regulation of epidermal cell differentiation(GO:0045604) |
| 0.0 |
0.0 |
GO:1904263 |
positive regulation of TORC1 signaling(GO:1904263) |
| 0.0 |
0.2 |
GO:0033623 |
regulation of integrin activation(GO:0033623) |
| 0.0 |
0.1 |
GO:0000083 |
regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0000083) |
| 0.0 |
0.1 |
GO:0002063 |
chondrocyte development(GO:0002063) |
| 0.0 |
0.1 |
GO:1900744 |
regulation of p38MAPK cascade(GO:1900744) |
| 0.0 |
0.1 |
GO:0045978 |
negative regulation of nucleoside metabolic process(GO:0045978) negative regulation of ATP metabolic process(GO:1903579) |
| 0.0 |
0.0 |
GO:0014005 |
microglia differentiation(GO:0014004) microglia development(GO:0014005) |
| 0.0 |
0.3 |
GO:0032435 |
negative regulation of proteasomal ubiquitin-dependent protein catabolic process(GO:0032435) |
| 0.0 |
0.3 |
GO:0071346 |
cellular response to interferon-gamma(GO:0071346) |
| 0.0 |
0.1 |
GO:0016255 |
attachment of GPI anchor to protein(GO:0016255) |
| 0.0 |
0.2 |
GO:1905209 |
positive regulation of cardiocyte differentiation(GO:1905209) |
| 0.0 |
0.1 |
GO:0006729 |
tetrahydrobiopterin biosynthetic process(GO:0006729) tetrahydrobiopterin metabolic process(GO:0046146) |
| 0.0 |
0.0 |
GO:0098869 |
cellular oxidant detoxification(GO:0098869) |
| 0.0 |
0.3 |
GO:0045540 |
regulation of cholesterol biosynthetic process(GO:0045540) |
| 0.0 |
0.0 |
GO:0072093 |
metanephric renal vesicle formation(GO:0072093) |
| 0.0 |
0.0 |
GO:0071787 |
endoplasmic reticulum tubular network assembly(GO:0071787) |
| 0.0 |
0.5 |
GO:0019319 |
hexose biosynthetic process(GO:0019319) |
| 0.0 |
0.1 |
GO:1902622 |
regulation of granulocyte chemotaxis(GO:0071622) regulation of neutrophil migration(GO:1902622) |
| 0.0 |
0.3 |
GO:0008584 |
male gonad development(GO:0008584) development of primary male sexual characteristics(GO:0046546) |
| 0.0 |
0.3 |
GO:1901380 |
negative regulation of potassium ion transmembrane transport(GO:1901380) |
| 0.0 |
0.0 |
GO:2001223 |
negative regulation of neuron migration(GO:2001223) |
| 0.0 |
0.0 |
GO:2000851 |
positive regulation of cortisol secretion(GO:0051464) positive regulation of glucocorticoid secretion(GO:2000851) |
| 0.0 |
0.2 |
GO:0032729 |
positive regulation of interferon-gamma production(GO:0032729) |
| 0.0 |
0.1 |
GO:0006398 |
mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
| 0.0 |
0.1 |
GO:2001056 |
positive regulation of cysteine-type endopeptidase activity(GO:2001056) |
| 0.0 |
0.1 |
GO:0046676 |
negative regulation of peptide secretion(GO:0002792) negative regulation of insulin secretion(GO:0046676) negative regulation of peptide hormone secretion(GO:0090278) |
| 0.0 |
0.3 |
GO:0061077 |
chaperone-mediated protein folding(GO:0061077) |
| 0.0 |
0.1 |
GO:0043392 |
negative regulation of DNA binding(GO:0043392) |
| 0.0 |
0.1 |
GO:0021869 |
forebrain ventricular zone progenitor cell division(GO:0021869) |
| 0.0 |
0.0 |
GO:0002314 |
germinal center B cell differentiation(GO:0002314) |
| 0.0 |
0.0 |
GO:0002578 |
negative regulation of antigen processing and presentation(GO:0002578) |
| 0.0 |
0.0 |
GO:0043388 |
positive regulation of DNA binding(GO:0043388) |
